datetime,headline,source,summary
18-10-2024,Danaher Gears Up to Report Q3 Earnings: What's in the Cards?,Yahoo,DHR's Q3 results are likely to be affected by weakness in the Biotechnology and Life Sciences segment.
18-10-2024,Madison Sustainable Equity Fund Q3 2024 Investment Strategy Letter,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
18-10-2024,Baron Health Care Fund Q3 2024 Shareholder Letter,SeekingAlpha,"In Q3 2024, Baron Health Care Fund advanced 5.81% (Inst), vs. 6.74% gain for the Russell 3000 Health Care Index (Benchmark). Click here to read the full letter."
18-10-2024,Spectris plc: It's A Great Time To Buy,SeekingAlpha,"Spectris is well-positioned to benefit from megatrends like electrification, decarbonization, and advanced manufacturing. See why SEPJF stock is a Buy."
18-10-2024,"Hedge Fund Billionaire Daniel Loeb Bets On Trump Win, Singles Out This Recent Buy As Having 'Significant Upside Potential'",Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
19-10-2024,"Dividend Champion, Contender, And Challenger Highlights: Week Of October 20",Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
19-10-2024,"Stocks to watch next week: Tesla, Lloyds, L'Oréal, Coca-Cola and Unilever",Yahoo,Earnings preview of key companies reporting next week and what to look out for.
20-10-2024,"Earnings week ahead: TSLA, GE, GM, KO, PM, LUV, AAL, VZ, T and more",Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
21-10-2024,Notable companies reporting before tomorrowâ????s open,Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
21-10-2024,Danaher Q3 2024 Earnings Preview,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
21-10-2024,Earnings Preview: Danaher,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
21-10-2024,Here's the major earnings before the open tomorrow,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
21-10-2024,Notable companies reporting before tomorrow’s open,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
22-10-2024,"Stock Markets Taper on High Valuations, Upcoming Election",Yahoo,In two weeks we potentially could see a number of prominent news items which could change the trajectory of stock market enthusiasm.
22-10-2024,Danaher (DHR) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates,Yahoo,"While the top- and bottom-line numbers for Danaher (DHR) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values."
22-10-2024,Danaher Third-Quarter Results Top Street Views; Affirms Full-Year Core Revenue Outlook,Yahoo,Danaher Third-Quarter Results Top Street Views; Affirms Full-Year Core Revenue Outlook
22-10-2024,"Stocks Fall, GM Eyes Best Day In A Year, Gold Breaks Records, Silver Hits 12-Year Highs: What's Driving Markets Tuesday?",Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
22-10-2024,"Life Science Giant Danaher Q3 Earnings: Revenue And EPS Beat, Sticks To  Annual Guidance",Yahoo,"On Tuesday, Danaher Corp (NYSE:DHR) reported third-quarter sales of $5.79 billion, up 3% year-over-year, beating the consensus of $5.59 billion. Non-GAAP core revenue increased by 0.5%, compared to the expectations of a decline in the low-single digits. Danaher reported second-quarter adjusted EPS of $1.71, beating the consensus of $1.57. Operating cash flow was $1.5 billion, and non-GAAP free cash flow was $1.2 billion. Also Read: Danaher Is Poised For ‘A Good Year In Bioprocessing’: Analyst. R"
22-10-2024,Danaher Corporation (DHR) Q3 2024 Earnings Call Transcript,SeekingAlpha,"Danaher Corporation (NYSE:DHR) Q3 2024 Earnings Call Transcript October 22, 2024 8:00 AM ETCompany ParticipantsJohn Bedford - VP of IRRainer Blair -..."
22-10-2024,Danaher (DHR) Tops Q3 Earnings and Revenue Estimates,Yahoo,"Danaher (DHR) delivered earnings and revenue surprises of 9.62% and 3.65%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?"
22-10-2024,Danaher Corp (DHR) Stock Price Down 3.14% on Oct 22,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
22-10-2024,A Closer Look at Danaher's Options Market Dynamics,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
22-10-2024,Danaher Corporation 2024 Q3 - Results - Earnings Call Presentation,SeekingAlpha,The following slide deck was published by Danaher Corporation in conjunction with their 2024 Q3 earnings call.
22-10-2024,Danaher: Q3 Earnings Snapshot,Yahoo,WASHINGTON (AP) — Danaher Corp. DHR) on Tuesday reported third-quarter net income of $818 million. The Washington-based company said it had profit of $1.12 per share.
22-10-2024,Danaher Reports Third Quarter 2024 Results,Yahoo,"Danaher Corporation (NYSE: DHR) (the ""Company"") today announced results for the quarter ended September 27, 2024. All results in this release reflect only continuing operations unless otherwise noted."
22-10-2024,Morning Movers: 3M gains and GE Aerospace falls following third quarter results,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
22-10-2024,Optimistic Outlook for Danaher Despite Short-Term Challenges in Bioprocessing Sector,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
22-10-2024,"Danaher 3Q EPS, Sales Top Views on Strong Cepheid Test Demand",Finnhub,"By Rob Curran Danaher Corp. posted third-quarter earnings and sales ahead of Wall Street expectations and backed its projection for 2024 sales growth, bolstered by growing demand for its Cepheid..."
22-10-2024,"Danaher : Quarterly Report for Quarter Ending September 27, 2024 (Form 10-Q)",Finnhub,"dhr-20240927 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ..."
22-10-2024,Danaher : Reports Third Quarter 2024 Results Form 8 K,Finnhub,"Danaher Reports Third Quarter 2024 Results WASHINGTON D.C., October 22, 2024 -- Danaher Corporation today announced results for the quarter ended September 27, 2024. All results in..."
22-10-2024,Danaher perks up as broad-based performance drives Q3 beat,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
22-10-2024,"Danaher Corp (DHR) Reports Q3 2024 Earnings: Adjusted EPS at $1.71, Revenue Reaches $5.8 Billion",GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
22-10-2024,Danaher backs FY24 revenue view down low-single digits,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
22-10-2024,"Danaher Non-GAAP EPS of $1.71 beats by $0.14, revenue of $5.8B beats by $210M",Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
22-10-2024,Danaher sees Q4 revenue down low-single digits,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
22-10-2024,"Danaher reports Q3 adjusted EPS $1.71, consensus $1.57",TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
22-10-2024,Danaher price target raised to $255 from $250 at Goldman Sachs,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
22-10-2024,"Danaher price target raised by $5 at Goldman Sachs, here's why",Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
23-10-2024,"Danaher price target lowered by $22 at RBC Capital, here's why",Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
23-10-2024,"Danaher Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line",Yahoo,Danaher ( NYSE:DHR ) Third Quarter 2024 Results Key Financial Results Revenue: US$5.80b (down 16% from 3Q 2023). Net...
23-10-2024,Danaher price target lowered to $300 from $310 at Raymond James,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
23-10-2024,"Danaher price target lowered by $10 at Raymond James, here's why",Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
23-10-2024,"Danaher price target raised by $15 at Stifel, here's why",Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
23-10-2024,"Danaher price target lowered by $10 at Barclays, here's why",Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
23-10-2024,"Danaher price target lowered by $1 at Baird, here's why",Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
23-10-2024,"Danaher price target raised by $5 at TD Cowen, here's why",Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
23-10-2024,"Danaher price target raised by $20 at KeyBanc, here's why",Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
23-10-2024,Jefferies Reaffirms Their Buy Rating on Danaher (DHR),TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
23-10-2024,Danaher Corp (DHR) Q3 2024 Earnings Call Highlights: Resilient Performance Amidst Market Challenges,Yahoo,"Danaher Corp (DHR) reports steady revenue and strategic acquisitions, while navigating headwinds in key markets."
23-10-2024,Decoding Danaher Corp (DHR): A Strategic SWOT Insight,Yahoo,Insightful Analysis of Danaher Corp's Market Position and Future Prospects
23-10-2024,Q3 2024 Danaher Corp Earnings Call,Yahoo,Q3 2024 Danaher Corp Earnings Call
23-10-2024,Danaher Breaks Below 200-Day Moving Average - Notable for DHR,Market News Video,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
23-10-2024,Jim Cramer on Danaher Corporation (DHR): ‘It’s A Very Important Position’,Yahoo,"We recently compiled a list of the Jim Cramer’s Game Plan: 23 Stocks to Watch. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the other stocks to watch according to Jim Cramer. As Wall Street dives into the heart of earnings season, Jim Cramer has provided insights […]"
23-10-2024,"Danaher's Q3 Earnings Boosted By Bioprocessing Order Growth, Analyst Maintain Stock Rating",Yahoo,"On Tuesday, Danaher Corp (NYSE:DHR) reported third-quarter sales of $5.79 billion, up 3% year-over-year, beating the consensus of $5.59 billion. Guidance: Danaher reaffirms that in fiscal year 2024, non-GAAP core revenue will be down in the low single digits year over year. The company forecasts that 2024 bioprocessing core revenue will decline in the low single digits, and Cepheid 2024 respiratory revenues will be around $1.7 billion compared to prior guidance of $1.6 billion. William Blair rep"
23-10-2024,"Danaher Q3 Earnings Surpass Estimates, Diagnostics Sales Up Y/Y",Yahoo,"DHR's third-quarter earnings and sales surpass estimates, benefiting from the solid performance of its Life Sciences and Diagnostics segments."
24-10-2024,Danaher price target raised to $265 from $250 at Stifel,Yahoo,"Stifel analyst Daniel Arias raised the firm’s price target on Danaher (DHR) to $265 from $250 and keeps a Hold rating on the shares. Q3 performance was above consensus on the top and the bottom lines, with the beat largely driven by Cepheid, but also helped by some bioprocess demand that surpassed expectations, the analyst tells investors. The post-earnings move in shares likely reflects questions on 2025 growth, but if “comfort can be gained with a low-teens EPS growth rate that puts EPS on a p"
24-10-2024,Danaher’s Resilience and Long-Term Potential Justifies Buy Rating Despite Short-Term Challenges,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
24-10-2024,U.S. companies exposed to the nuclear energy trend,Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
25-10-2024,Understanding Danaher's Cautiousness,SeekingAlpha,Discover the cautious optimism behind Danaher's Q3 earnings report and why management is hesitant to provide specific numbers in this article.
26-10-2024,Want to Grow a Passive Income Snowball? Buy These 7 Elite Dividend Growth Stocks.,Yahoo,These seven companies are transforming steady profits into rising passive income streams for investors.
28-10-2024,Danaher (DHR) Reliance on International Sales: What Investors Need to Know,Yahoo,Examine Danaher's (DHR) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.
28-10-2024,"If You Invested $1000 In This Stock 10 Years Ago, You Would Have $4,600 Today",Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
28-10-2024,Daniel Loeb's Strategic Reduction in Bath & Body Works Inc.,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
29-10-2024,Parnassus Growth Equity Fund Q3 2024 Commentary,SeekingAlpha,"Parnassus Growth Equity Fund (I) returned 3.29% (net) for the quarter, outperforming the Russell 1000 Growth Indexâs 3.19%. Click here to read the full fund letter. "
29-10-2024,"Danaher Corp. stock falls Tuesday, underperforms market",MarketWatch,"Danaher Corp. stock falls Tuesday, underperforms market"
30-10-2024,"Danaher Corp. stock falls Wednesday, still outperforms market",MarketWatch,"Danaher Corp. stock falls Wednesday, still outperforms market"
31-10-2024,"Danaher upgraded to outperform by Wolfe, recent stock drop cited",Seeking Alpha,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
31-10-2024,"Wingstop upgraded, Estee Lauder downgraded: Wall Street’s top analyst calls",TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
31-10-2024,"Wingstop upgraded, Estee Lauder downgraded: Wall Street's top analyst calls",Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
31-10-2024,Danaher Corp: An Exploration into Its Intrinsic Value,GuruFocus,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
31-10-2024,"Danaher Corp. stock rises Thursday, outperforms market",MarketWatch,"Danaher Corp. stock rises Thursday, outperforms market"
31-10-2024,Danaher upgraded to Outperform from Peer Perform at Wolfe Research,TipRanks,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
31-10-2024,"Danaher just upgraded at Wolfe Research, here's why",Thefly.com,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
01-11-2024,Here’s Why Baron Health Care Fund Added Danaher Corporation (DHR) to its Portfolio,Yahoo,"Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund appreciated 5.81%% (Institutional Shares) in the quarter compared to a 6.74% gain for the Russell 3000 Health Care Index (benchmark) and a 6.23% gain for the Russell […]"
01-11-2024,Danaher : Powering a new paradigm for pathology,Finnhub,"To address this issue, Dr. Rimm and his lab developed a new, high sensitivity HER2 assay in 2022. Our solution doesn't force the pathologist to judge the level, but instead utilizes their ability to..."
01-11-2024,"Danaher Corp. stock rises Friday, outperforms market",MarketWatch,"Danaher Corp. stock rises Friday, outperforms market"
01-11-2024,A Look Into Danaher Inc's Price Over Earnings,Benzinga,Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.
01-11-2024,Wolfe Research Upgrades Danaher (DHR),Fintel,
04-11-2024,"Danaher Corp. stock falls Monday, still outperforms market",MarketWatch,"Danaher Corp. stock falls Monday, still outperforms market"
05-11-2024,"Danaher Corp. stock rises Tuesday, still underperforms market",MarketWatch,"Danaher Corp. stock rises Tuesday, still underperforms market"
07-11-2024,"Danaher Corp. stock falls Wednesday, underperforms market",MarketWatch,"Danaher Corp. stock falls Wednesday, underperforms market"
08-11-2024,"Danaher Corp. stock falls Thursday, underperforms market",MarketWatch,"Danaher Corp. stock falls Thursday, underperforms market"
12-11-2024,Danaher : Building a virtual 4D cell,Finnhub,"Putting biology in place At the core of creating the virtual cell is understanding not just how proteins are shaped, but where they are located within the cell. For a long time,..."
12-11-2024,"Danaher Corp. stock falls Monday, underperforms market",MarketWatch,"Danaher Corp. stock falls Monday, underperforms market"
13-11-2024,Weitz Conservative Allocation Fund Q3 2024 Commentary,SeekingAlpha,The Conservative Allocation Fund's Institutional Class returned +4.82% for the third quarter compared to +6.32% for the Morningstar Moderately Conservative Target Risk Index.
13-11-2024,"Danaher Corp. stock falls Tuesday, underperforms market",MarketWatch,"Danaher Corp. stock falls Tuesday, underperforms market"
14-11-2024,Thermo Fisher Scientific: Near The Bottom And Attractively Valued,SeekingAlpha,Thermo Fisher Scientific has good revenue and margin growth prospects ahead and is trading at a discount. See why TMO stock is a Buy.
14-11-2024,"Danaher Corp. stock rises Wednesday, outperforms market",MarketWatch,"Danaher Corp. stock rises Wednesday, outperforms market"
15-11-2024,Health advocates press Cepheid for cheaper mpox tests,Finnhub,"Global health advocates have written to the makers of a key mpox diagnostic test to call for its price to be cut from around $20 per test to $5, to help tackle low testing rates in poorer countries..."
15-11-2024,Revving Up: 2 Underperforming Dividend Giants Ready To Outshine,SeekingAlpha,Two dividend stocks are well-positioned for growth after adapting to challenges. Find out why CP and DHR offer solid returns and potential for a strong rebound.
15-11-2024,"Danaher Corp. stock falls Thursday, underperforms market",MarketWatch,"Danaher Corp. stock falls Thursday, underperforms market"
16-11-2024,"Danaher Corp. stock falls Friday, underperforms market",MarketWatch,"Danaher Corp. stock falls Friday, underperforms market"
19-11-2024,Danaher Corporation (DHR) Highlighted Milestones in its 2024 Corporate Sustainability Report,Yahoo,"Madison Investments, an investment advisor, released its “Madison Sustainable Equity Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. All equity classes experienced good results in the third quarter. During the quarter, equity markets ended on a high note, with the S&P 500 achieving a 5.89% increase, bringing the full-year […]"
19-11-2024,Fidelity Select Health Care Portfolio Q3 2024 Fund Review,SeekingAlpha,"For Q3 2024, the Fidelity Select Health Care Portfolio fund gained 9.48%, outperforming the MSCI sector index. Click here to read the full commentary."
19-11-2024,"Danaher Corp. stock falls Monday, underperforms market",MarketWatch,"Danaher Corp. stock falls Monday, underperforms market"
20-11-2024,BlackRock Event Driven Equity Fund Q3 2024 Commentary,SeekingAlpha,"BlackRock Event Driven Equity Fund The Fund was up over the quarter with hard catalyst, soft catalyst, and credit investments all contributing to returns."
20-11-2024,"Danaher Corp. stock rises Tuesday, still underperforms market",MarketWatch,"Danaher Corp. stock rises Tuesday, still underperforms market"
21-11-2024,Franklin DynaTech SMA Q3 2024 Commentary,SeekingAlpha,"Global equities ended 3Q24 collectively higher as they recovered from bouts of heightened volatility, including a market selloff in early August following an interest rate hike by the BoJ."
21-11-2024,Franklin DynaTech Fund Q3 2024 Commentary,SeekingAlpha,"Global equities ended the third quarter collectively higher as they recovered from bouts of volatility, some of which was stoked by US recession concerns."
21-11-2024,Tracking Akre Capital Management Portfolio - Q3 2024 Update,SeekingAlpha,"Read here for the latest updates on Akre Capital Management's 13F portfolio, with major holdings and significant stake changes in top companies."
21-11-2024,"Danaher Corp. stock rises Wednesday, outperforms market",MarketWatch,"Danaher Corp. stock rises Wednesday, outperforms market"
22-11-2024,Genedata: Powering Biopharma AI,Finnhub,"In the age of AI and machine learning, data is more valuable than ever before. However, biopharma companies often lack the high-quality, structured data needed to power advanced models to generate..."
22-11-2024,"Danaher Corp. stock rises Thursday, outperforms market",MarketWatch,"Danaher Corp. stock rises Thursday, outperforms market"
23-11-2024,Danaher Corp (NYSE:DHR): A Bullish Investment Perspective,Yahoo,"We came across a bullish thesis on Danaher Corp (DHR) on ValueInvestorsClub by valueinvestor03. In this article, we will summarize the bulls’ thesis on DHR. DHR’s stock was trading at $250 when this thesis was published, vs. a closing price of $230.84 on November 19. DHR is a diversified life sciences company with immense growth and evolution, […]"
23-11-2024,"Danaher Corp. stock rises Friday, still underperforms market",MarketWatch,"Danaher Corp. stock rises Friday, still underperforms market"
24-11-2024,Franklin U.S. Focused Growth SMA Q3 2024 Commentary,SeekingAlpha,"Franklin U.S. Focused Growth SMA strategy posted absolute gains in 6 out of 9 equity sector allocations during 3Q24, but it underperformed Russell 1000 Growth Index."
25-11-2024,Tracking Al Gore's Generation Investment Management Portfolio - Q3 2024 Update,SeekingAlpha,Generation Investment Management's 13F portfolio value increased to $21.41B. Read more to see the portfolio's full Q3 2024 update.
26-11-2024,Invesco Health Care Fund Q3 2024 Commentary,SeekingAlpha,"Invesco Health Care Fund underperformed its benchmark. Despite earlier signs of improving trends, our health care outlook is bearish. Read more here."
26-11-2024,Veralto: Premium Multiples For A Premium Business,SeekingAlpha,Veralto's premium valuation is justified by its accelerating organic growth and strategic investments. Learn why VLTO stock is a Hold.
26-11-2024,"Danaher Corp. stock rises Monday, outperforms market",MarketWatch,"Danaher Corp. stock rises Monday, outperforms market"
27-11-2024,Illinois Tool Works: Customer-Back Innovation And Improving Macros To Drive Upside,SeekingAlpha,"Illinois Tool Works is poised for growth with innovative strategies and a positive margin outlook, offering a potential 11-12% return. Learn more on ITW stock here."
27-11-2024,Invesco Main Street Fund Q3 2024 Commentary,SeekingAlpha,"Underperformance mainly resulted from stock selection in the consumer discretionary, financials and industrials sectors."
27-11-2024,Danaher to Present at Evercore ISI HealthCONx Conference,Yahoo,"Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Evercore ISI HealthCONx Conference in Coral Gables, Florida on Wednesday, December 4, 2024 at 3:25 p.m. ET. The event will be simultaneously webcast on www.danaher.com."
29-11-2024,Harding Loevner Global Equity ADR Q3 2024 Report,SeekingAlpha,"The Global Equity ADR composite rose 5.3% gross of fees in the third quarter of 2024, trailing the 6.7% gain in the MSCI ACWI Index. Click here to read the full commentary. "
30-11-2024,ESAB Can Continue To Outperform,SeekingAlpha,"ESAB Corporation's stock has risen over 35%, driven by improving growth outlook, strong execution, and potential M&As."
30-11-2024,"Danaher Corp. stock rises Friday, still underperforms market",MarketWatch,"Danaher Corp. stock rises Friday, still underperforms market"
03-12-2024,Harding Loevner Global Developed Markets Equity Q3 2024 Report,SeekingAlpha,"Global markets advanced during the third quarter of 2024, with all regions posting gains. Click here to read the full commentary."
03-12-2024,Tracking Dan Loeb's Third Point Portfolio - Q3 2024 Update,SeekingAlpha,"Read here for an update on Dan Loeb's Third Point 13F portfolio changes, including new stakes, disposals, and major stake increases and decreases."
03-12-2024,"Danaher Corp. stock rises Monday, outperforms market",MarketWatch,"Danaher Corp. stock rises Monday, outperforms market"
04-12-2024,Danaher : How we’re supporting the Human Immunome Project,Finnhub,"The immune system is the nexus of human health. This complex and dynamic system is essential in protecting us from disease, promoting healing, and maintaining overall well-being throughout our lives...."
04-12-2024,"Danaher Corp. stock falls Tuesday, underperforms market",MarketWatch,"Danaher Corp. stock falls Tuesday, underperforms market"
05-12-2024,BNY Mellon Dynamic Value Fund Q3 2024 Commentary,SeekingAlpha,BNY Mellon Dynamic Value Fund (Class A at NAV) returned 8.96% during the third quarter of 2024. Read more here.
05-12-2024,Danaher Corporation (DHR) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript),SeekingAlpha,"Danaher Corporation (NYSE:DHR) Annual Evercore ISI HealthCONx Healthcare Conference December 4, 2024 3:25 PM ETCompany ParticipantsRainer Blair - President..."
05-12-2024,"Danaher Corp. stock falls Wednesday, underperforms market",MarketWatch,"Danaher Corp. stock falls Wednesday, underperforms market"
06-12-2024,"Unicorn AIM VCT ""cautiously optimistic"" despite some ""headwinds""",Finnhub,"Unicorn AIM VCT PLC on Friday said its net asset value declined over the course of its financial year, despite perking up from where it stood at the end of the first-half. Net asset value per share..."
06-12-2024,"Danaher Corp. stock falls Thursday, underperforms market",MarketWatch,"Danaher Corp. stock falls Thursday, underperforms market"
07-12-2024,"Danaher Corp. stock rises Friday, outperforms market",MarketWatch,"Danaher Corp. stock rises Friday, outperforms market"
10-12-2024,Here's Why You Should Avoid Investing in Danaher Stock Right Now,Yahoo,DHR experiences weakness in its operations due to softness in the Life Sciences segment. Rising expenses are added concerns.
10-12-2024,Thermo Fisher Scientific: Renewed Growth Momentum After The Pandemic,SeekingAlpha,"Thermo Fisher Scientific's valuation multiples offer potential capital appreciation. Learn why TMO stock is a Buy, with growth drivers in 2025 and beyond."
10-12-2024,Danaher : Top five takeaways from the 2024 Danaher Summit,Finnhub,Some of AI's most profound insights in life science and medicine are due to its ability to work across multiple dimensions at the same time. We can now layer many different kinds of data on top of one...
10-12-2024,Danaher: A Resilient And Solid Company With Growth Potential,SeekingAlpha,"Danaher thrives on strategic growth acquisitions, boasting high earnings margins and low liabilities-to-assets ratio for a promising financial future. Read more here."
10-12-2024,"Danaher Corp. stock rises Monday, outperforms market",MarketWatch,"Danaher Corp. stock rises Monday, outperforms market"
11-12-2024,Here’s Why Parnassus Growth Equity Fund Sold Danaher Corp. (DHR),Yahoo,"Parnassus Investments, an investment management company, released the “Parnassus Growth Equity Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. In the third quarter, the Fund (Investor Shares) returned 3.29% (net of fees) outperforming the Russell 1000 Growth Index’s 3.19% gain. Stock selection in the Health Care sector primarily […]"
11-12-2024,Danaher Announces Quarterly Dividend,Yahoo,"Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share of its common stock, payable on January 31, 2025 to holders of record on December 27, 2024."
11-12-2024,"Danaher Corp. stock falls Tuesday, underperforms market",MarketWatch,"Danaher Corp. stock falls Tuesday, underperforms market"
12-12-2024,"Danaher Corp. stock rises Wednesday, still underperforms market",MarketWatch,"Danaher Corp. stock rises Wednesday, still underperforms market"
13-12-2024,Thermo Fisher: The Cycle Has Already Turned Around,SeekingAlpha,"Thermo Fisher stock is a buy with signs of recovery and potential growth, backed by positive sales and margins. Read an analysis of TMO stock here."
14-12-2024,B of A Securities Upgrades Danaher (DHR),Fintel,
14-12-2024,"Best Way To Invest $100,000: Build An 8-Stock Portfolio For Growth And Value",SeekingAlpha,Learn how to maximize returns by focusing on high-conviction stocks across diverse sectors and using proven investment strategies.
14-12-2024,"Despite Higher Valuations, Some Life Sciences Tools Stocks Create Good Opportunities: Analyst",Yahoo,"BofA Securities reports that the Life Sciences Tools sector struggled in fiscal year 2024. Spending by pharmaceutical and biotech companies dropped after pandemic-related overspending, and demand in China stayed weak. This led some Life Sciences companies to lower their already-conservative fiscal year revenue forecasts as the year progressed. For most of fiscal year 2024, Life Sciences company valuations remained higher than pre-COVID levels but declined after the U.S. elections. Looking ahead"
14-12-2024,"Danaher Corp. stock rises Friday, outperforms market",MarketWatch,"Danaher Corp. stock rises Friday, outperforms market"
16-12-2024,Why Danaher Corporation (DHR) Is the Best Stock to Buy for the Long-Term According to Charles Akre?,Yahoo,"We recently published a list of 10 Best Stocks to Buy for the Long-Term According to Charles Akre. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other best stocks to buy for the long-term according to Charles Akre. “Above-average returns at below-average risk” is the mantra […]"
17-12-2024,"Danaher Corp. stock falls Monday, underperforms market",MarketWatch,"Danaher Corp. stock falls Monday, underperforms market"
18-12-2024,Hartford Global Impact Fund Q3 2024 Commentary,SeekingAlpha,The Hartford Global Impact Fund (I share) outperformed the MSCI ACWI Index during the quarter. Read more here.
19-12-2024,Danaher Corp. stock outperforms market despite losses on the day,MarketWatch,Danaher Corp. stock outperforms market despite losses on the day
20-12-2024,"Danaher Corp. stock falls Thursday, underperforms market",MarketWatch,"Danaher Corp. stock falls Thursday, underperforms market"
21-12-2024,Cramer Criticizes Danaher (DHR) for Lackluster Performance and Unimpressive Guidance,Yahoo,"We recently published a list of 14 Stocks That Jim Cramer Recently Talked About. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Jim Cramer recently talked about. In his latest appearance on CNBC’s Squawk on the Street, Jim Cramer continued to talk about […]"
22-12-2024,"Dividend Champion, Contender, And Challenger Highlights: Week Of December 22",SeekingAlpha,"A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends."
23-12-2024,Hartford Healthcare Fund Q3 2024 Commentary,SeekingAlpha,The Hartford Healthcare Fund (I Share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.
24-12-2024,Scotiabank Initiates Coverage of Danaher (DHR) with Sector Perform Recommendation,Fintel,
24-12-2024,Jim Cramer Reports That Danaher Corporation (DHR)’s China Core Revenue Dropped By A ‘High-single-digit’ Percent In Q3,Yahoo,"We recently compiled a list of the Jim Cramer Latest Stocks: 23 Stocks He Just Talked About. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the other stocks Jim Cramer recently talked about. With the Federal Reserve’s December meeting over, Wall Street has now shifted into a […]"
24-12-2024,"Danaher Corp. stock rises Monday, still underperforms market",MarketWatch,"Danaher Corp. stock rises Monday, still underperforms market"
25-12-2024,"Keepin' It Contrarian: Moat Index Adds Health Care, Reduces Tech",SeekingAlpha,"The MorningstarÂ® Wide Moat Focus IndexSM underwent its quarterly review on December 20, 2024. 13 companies rotated in and out of the Moat Index during its December quarterly rebalance."
25-12-2024,"Danaher Corp. stock rises Tuesday, still underperforms market",MarketWatch,"Danaher Corp. stock rises Tuesday, still underperforms market"
29-12-2024,Jim Cramer on Danaher Corporation (DHR): ‘We Stuck With Danaher Because We Have Tremendous Respect For The Company’,Yahoo,"We recently compiled a list of the 8 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the other stocks. Jim Cramer, the host of Mad Money, recently shared some investment guidelines based on his 40 years of experience. As we previously discussed […]"
03-01-2025,Danaher price target lowered to $268 from $278 at Evercore ISI,Yahoo,"Evercore ISI lowered the firm’s price target on Danaher (DHR) to $268 from $278 and keeps an Outperform rating on the shares. In the firm’s 2025 outlook note for MedTech, Life Science Tools and Diagnostics, the analyst argues that FY25 guides from the life science tools group are likely to be conservative on China and Pharma, while in MedTech the firm contends that “healthy” utilization trends and a margin expansion thesis support the group. Published first on TheFly – the ultimate source for re"
03-01-2025,Danaher Schedules Fourth Quarter 2024 Earnings Conference Call,Yahoo,"Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2024 on Wednesday, January 29, 2025 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations."
03-01-2025,"Danaher Corp. stock rises Thursday, outperforms market",MarketWatch,"Danaher Corp. stock rises Thursday, outperforms market"
04-01-2025,Will Danaher (DHR) Beat Estimates Again in Its Next Earnings Report?,Yahoo,Danaher (DHR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
06-01-2025,Danaher: A Wide-Moat Gem I Cannot Buy Enough Of,SeekingAlpha,"Discover why Danaher is a strong investment choice with its wide moat business model, M&A strategy, and growth potential for total return investors."
07-01-2025,Danaher price target lowered to $285 from $305 at Citi,Yahoo,"Citi analyst Patrick Donnelly lowered the firm’s price target on Danaher (DHR) to $285 from $305 and keeps a Buy rating on the shares. Outside of the preannouncements and guidance updates from life science tools and diagnostics names in January, Citi expects key themes to include the cadence and magnitude of the expected recoveries in areas such as China and bioprocessing, the rollout of the China stimulus program, trends within the instrumentation replacement cycle, general biopharma health and"
07-01-2025,Danaher to Present at J.P. Morgan Healthcare Conference,Yahoo,"Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 14, 2025 at 11:15 a.m. PT. The event will be simultaneously webcast and can be accessed on the ""Investors"" section of Danaher's website, www.danaher.com, under the subheading ""Events & Presentations."""
08-01-2025,CURE: Analyst Estimates Point To Significant Gains In 2025,SeekingAlpha,The Direxion Daily Healthcare Bull 3X Shares ETF seeks to deliver 300% (3x) of the return of an index focused on large-cap US healthcare stocks.
08-01-2025,"Danaher Corp. stock rises Tuesday, outperforms market",MarketWatch,"Danaher Corp. stock rises Tuesday, outperforms market"
10-01-2025,Danaher Announces Investment Partnership in Innovaccer Inc.,Yahoo,"Danaher Diagnostics LLC and Danaher Ventures LLC, two subsidiaries of Danaher Corporation (NYSE: DHR) (""Danaher""), a global science and technology innovator, announced today that they have formed an investment partnership with Innovaccer Inc., a leading healthcare artificial intelligence (AI) company."
10-01-2025,Danaher Invests in AI Healthcare Company,Finnhub,"By Connor Hart Two Danaher subsidiaries have formed what the company called an investment partnership with Innovaccer, a healthcare artificial-intelligence company. The partnership aims to..."
13-01-2025,"Using SA's Stock Screener: Sell 6 Overvalued Blue Chips, With Stagnating Growth",SeekingAlpha,"Seeking Alpha identifies 6 blue-chip stocks with high valuations and limited growth. Learn why Costco, EstÃ©e Lauder, and others may disappoint in 2025."
13-01-2025,Dividend Growth Investing: The Strategy That Always Wins,SeekingAlpha,"Learn how dividend investing can provide stability, growth, and inflation protection in uncertain markets, leading to lasting financial success."
14-01-2025,Franklin DynaTech Fund Q4 2024 Commentary,SeekingAlpha,"As a result of stock selection and allocation decisions, the fund underperformed its benchmark as seven out of 11 equity sectors detracted. Read more here."
14-01-2025,Mawer Investment Management Q4 2024 Quarterly Update,SeekingAlpha,"Global central banks continued to ease this quarter, though the pace of easing varied. Click here to read the full commentary. "
14-01-2025,Danaher : Supplemental Information,Finnhub,"Update on the 4th Quarter 2024 Q4 core revenue expected to be essentially flat, exceeding our expectations Bioprocessing performance in line with..."
14-01-2025,Danaher CEO to Comment on Financial Performance,Finnhub,"WASHINGTON, Jan. 13, 2025 /PRNewswire/ -- Danaher Corporation announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Company's fourth quarter 2024..."
15-01-2025,Beckman Coulter Introduces Cutting-Edge Research Use Only Assays for Neurodegenerative Disease Research,Finnhub,"New, Fully Automated, High-Throughput RUO Assays offered on Beckman Coulter Immunoassay Analyzers BREA, Calif., Jan. 15, 2025 /PRNewswire/ -- Beckman Coulter Diagnostics, a global leader in..."
15-01-2025,Danaher Corporation: Question Mark Behind The Moat And Probably Overvalued,SeekingAlpha,"Financial writer analyzes Danaher Corporation's mixed performance, growth potential, economic moat, and current overvaluation as a Hold stock."
15-01-2025,Danaher Corporation (DHR) 43rd Annual J.P. Morgan Healthcare Conference (Transcript),SeekingAlpha,"Danaher Corporation (NYSE:DHR) 43rd Annual J.P. Morgan Healthcare Conference January 14, 2024 2:15 PM ETCompany ParticipantsRainer Blair - President and..."
15-01-2025,"Danaher Corp. stock falls Tuesday, underperforms market",MarketWatch,"Danaher Corp. stock falls Tuesday, underperforms market"
16-01-2025,Akre Focus Fund Q4 2024 Commentary,SeekingAlpha,The Akre Focus Fundâs fourth quarter 2024 performance for the Institutional share class wasÂ -0.41% compared with S&P 500 Total Return at 2.41%. Read more here.
16-01-2025,Danaher: Transition Year Recap,SeekingAlpha,"Danaher executed a $4.5 billion share buyback, with an additional 20 million shares authorized. Learn why I remain bullish on DHR stock."
16-01-2025,The Near-Perfect Dividend Portfolio With 10 Sleep-Well-At-Night Gems,SeekingAlpha,
20-01-2025,IYH: Healthcare Dashboard For January,SeekingAlpha,iShares U.S. Healthcare ETF has higher fees and lower performance. See why IYH is a top choice and learn about 10 cheaper healthcare stocks this January.
21-01-2025,Aldevron Unveils Next-Generation Alchemy™ Cell-Free DNA Technology for Research Grade Applications,Finnhub,"Aldevron, a global leader in the production of DNA, RNA and protein, has launched its latest innovation, Alchemy™ cell-free DNA technology. This revolutionary technology represents a significant..."
22-01-2025,Baron Health Care Fund Q4 2024 Shareholder Letter,SeekingAlpha,"Baron Health Care Fund retreated in the fourth quarter of 2024, in line with its benchmark, the Russell 3000 Health Care Index. Read more here."
22-01-2025,Aldevron Unveils Next-Generation Alchemy Cell-Free DNA Technology for Research Grade Applications,Finnhub,"FARGO, N.D. - Aldevron, a global leader in the production of DNA, RNA and protein, has launched its latest innovation, Alchemy cell-free DNA technology. This revolutionary technology represents a..."
22-01-2025,"Danaher Corp. stock rises Tuesday, outperforms market",MarketWatch,"Danaher Corp. stock rises Tuesday, outperforms market"
23-01-2025,This Healthcare Stock Might Just Be RFK Jr. Proof,MarketWatch,This Healthcare Stock Might Just Be RFK Jr. Proof
24-01-2025,NZS Capital Q4 2024 Shareholder Letter,SeekingAlpha,The NZS Growth Equity strategy declined 1.09% in the fourth quarter of 2024 and returned 21.25% for the full year.
25-01-2025,"Dividend Champion, Contender, And Challenger Highlights: Week Of January 26",SeekingAlpha,"Stay informed with weekly updates on dividend activity for Dividend Champions, Contenders, and Challengers, including changes and upcoming dates."
26-01-2025,Abbott Laboratories: Strong Q4 Results And Bullish Outlook,SeekingAlpha,"Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS increase."
28-01-2025,"Danaher Corp. stock rises Monday, outperforms market",MarketWatch,"Danaher Corp. stock rises Monday, outperforms market"
29-01-2025,Danaher Stock Falls the Most Since 2023. Why Earnings Were Such a Disappointment.,Yahoo,"The company reported fourth-quarter earnings per share of $2.14, while Wall Street was looking for $2.16."
29-01-2025,Danaher Fourth-Quarter Earnings Miss Estimates; Expects Decline in Core Revenue,Yahoo,"Danaher (DHR) on Wednesday reported fourth-quarter earnings that fell short of market estimates, whi"
29-01-2025,Danaher (DHR) Lags Q4 Earnings Estimates,Yahoo,"Danaher (DHR) delivered earnings and revenue surprises of -1.38% and 1.22%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?"
29-01-2025,Danaher Q4: EPS Miss Expectations Amid Diagnostics Segment Lag,Yahoo,"Danaher Corporation (NYSE:DHR) shares are trading lower in the premarket session on Wednesday. The company reported fourth-quarter adjusted earnings per share of $2.14 missing the street view of $2.16. Quarterly sales of $6.54 billion (+2%) beat the analyst consensus estimate of $6.42 billion. The Biotechnology segment gained 6.5% year over year in the quarter under review, while the Life Sciences segment rose 5.5%. The Diagnostics segment sales decreased by 3% year over year. The company exited"
29-01-2025,Danaher Corporation (DHR) Q4 2024 Earnings Call Transcript,SeekingAlpha,"Danaher Corporation (NYSE:DHR) Q4 2024 Earnings Conference Call January 29, 2025 8:00 AM ETCompany ParticipantsJohn Bedford - VP of IRRainer Blair -..."
29-01-2025,Danaher Corporation 2024 Q4 - Results - Earnings Call Presentation,SeekingAlpha,The following slide deck was published by Danaher Corporation in conjunction with their 2024 Q4 earnings call.
29-01-2025,"ASML stock pops, and other movers",MarketWatch,"ASML stock pops, and other movers"
29-01-2025,"Danaher 4Q Revenue Rises on Gains in Life Sciences, Biotech",Finnhub,"By Dean Seal Danaher reported higher earnings and revenue in the fourth quarter from gains in its life-sciences and biotechnology units, though it expects the top line to decline in the first..."
29-01-2025,Danaher: Q4 Earnings Snapshot,Finnhub,"WASHINGTON — WASHINGTON — Danaher Corp. on Wednesday reported fourth-quarter net income of $1.09 billion. The Washington-based company said it had profit of $1.49 per share. Earnings,..."
29-01-2025,Danaher : 2024 Q4 PresentationPresentationPresentationPresentation,Finnhub,"Danaher Corporation Fourth Quarter 2024 Earnings Release January 29, 2025 ..."
29-01-2025,Danaher : 2024 Q4 Non GAAP RecsNon GAAP RecsNon GAAP RecsNon GAAP Recs,Finnhub,DANAHER CORPORATION RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES AND SUPPLEMENTAL FORWARD-LOOKING INFORMATION THREE-MONTH...
29-01-2025,Danaher Reports Fourth Quarter and Full Year 2024 Results,Finnhub,"WASHINGTON, Jan. 29, 2025 /PRNewswire/ -- Danaher Corporation today announced results for the fourth quarter and full year 2024.  All results in this release reflect only continuing operations..."
29-01-2025,"Microsoft, Meta and Tesla kick off Big Tech earnings season",MarketWatch,"Microsoft, Meta and Tesla kick off Big Tech earnings season"
29-01-2025,Danaher : 2024 Q2 Press Release,Finnhub,"Danaher Corporation Investors Danaher Reports Second Quarter 2024 Results WASHINGTON, July 23, 2024 /PRNewswire/ -- Danaher Corporation today announced..."
29-01-2025,Danaher : 2024 Q3 Press Release,Finnhub,"Danaher Corporation Investors Danaher Reports Third Quarter 2024 Results WASHINGTON, Oct. 22, 2024 /PRNewswire/ -- Danaher Corporation today announced..."
29-01-2025,Danaher : 2024 Q1 Press Release,Finnhub,"Danaher Corporation Investors Danaher Reports First Quarter 2024 Results WASHINGTON, April 23, 2024 /PRNewswire/ -- Danaher Corporation today announced..."
29-01-2025,"Danaher Corp. stock falls Tuesday, underperforms market",MarketWatch,"Danaher Corp. stock falls Tuesday, underperforms market"
30-01-2025,Zacks Earnings Trends Highlights: Royal Caribbean and Danaher,Yahoo,Royal Caribbean and Danaher are part of the Zacks Earnings Trends article.
30-01-2025,Why Danaher Corp. (DHR) Crashed on Wednesday?,Yahoo,"We recently published a list of These 10 Stocks Were Wednesday’s Worst Performers. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands among Wednesday’s worst-performing stocks. The stock market declined on Wednesday, with all major indices finishing in the red, driven by losses in technology stocks. The Nasdaq […]"
30-01-2025,Q4 2024 Danaher Corp Earnings Call,Yahoo,Q4 2024 Danaher Corp Earnings Call
30-01-2025,Broad-Based Sector Growth Expected for 2025,Yahoo,"2025 is expected to have all 16 Zacks sectors enjoy earnings growth, with eight expected to produce double-digit growth. But what else should investors know?"
30-01-2025,Danaher Stock Tanks 8.6% After Rare Earnings Miss--Is the Growth Story Cracking?,Yahoo,"Wall Street expected another Danaher beat, but weak margins and a gloomy forecast sent investors rushing for the exits."
30-01-2025,"Danaher Q4 Earnings Miss Estimates, Life Sciences Sales Rise Y/Y",Yahoo,"DHR's fourth-quarter sales increase 2.1% year over year, benefiting from the solid performance of its Life Sciences and Biotechnology segments."
30-01-2025,"Danaher Corp. stock falls Wednesday, underperforms market",MarketWatch,"Danaher Corp. stock falls Wednesday, underperforms market"
30-01-2025,Danaher (DHR) Reports Q4 Earnings: What Key Metrics Have to Say,Yahoo,"The headline numbers for Danaher (DHR) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals."
31-01-2025,Danaher price target lowered to $260 from $265 at Stifel,Yahoo,"Stifel lowered the firm’s price target on Danaher (DHR) to $260 from $265 and keeps a Hold rating on the shares. Danaher being conservative with the initial FY25 outlook was “not a surprise for many,” but numbers themselves combined with “a rare EPS miss, made for a messier situation than was envisioned,” the analyst tells investors. The report “may be the clearing event needed for the stock, though some level of confidence in upside must be had,” the analyst added. Published first on TheFly – t"
31-01-2025,Danaher Corporation Just Missed EPS By 5.5%: Here's What Analysts Think Will Happen Next,Yahoo,"Danaher Corporation ( NYSE:DHR ) shareholders are probably feeling a little disappointed, since its shares fell 9.2% to..."
31-01-2025,Danaher Corp (DHR) Q4 2024 Earnings Call Highlights: Strategic Growth Amid Market Challenges,Yahoo,"Danaher Corp (DHR) reports robust cash flow and strategic acquisitions, despite facing revenue headwinds and market uncertainties."
01-02-2025,Why Danaher Corporation (DHR) Is Among the Best Long Term Low Risk Stocks to Buy Now,Yahoo,"We recently compiled a list of the 12 Best Long Term Low Risk Stocks to Buy Right Now. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the other long term low risk stocks. As the DeepSeek craze ignites a sell-off in the tech sector, investors are weighing […]"
01-02-2025,Jim Cramer Says He’s ‘Extremely Disappointed’ In Danaher Corporation (DHR),Yahoo,"We recently published an article titled Jim Cramer Discusses These 10 Stocks & Says He’s In Waiting For AI GPU Spending Clarity. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the other stocks Jim Cramer recently discussed. In his latest appearance on CNBC’s Squawk on the Street, […]"
01-02-2025,Danaher’s (NYSE:DHR) Q4 Sales Beat Estimates,Yahoo,"Diversified science and technology company Danaher (NYSE:DHR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.1% year on year to $6.54 billion. Its non-GAAP profit of $2.14 per share was 1.3% below analysts’ consensus estimates."
03-02-2025,Raymond James Downgrades Danaher (DHR),Fintel,
04-02-2025,Baron Durable Advantage Fund Q4 2024 Shareholder Letter,SeekingAlpha,"Baron Durable Advantage Fund advanced during the fourth quarter of 2024, outpacing its benchmark, the S&P 500 Index."
04-02-2025,Is Danaher Corporation (DHR) the Best Cancer Stock to Buy According to Hedge Funds?,Yahoo,"We recently published a list of the 10 Best Cancer Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other best cancer stocks to buy. Overview of the Global Oncology Sector Cancer is the second leading cause of death across […]"
04-02-2025,Danaher Corp. stock underperforms Monday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Monday when compared to competitors
04-02-2025,Raymond James downgrades Danaher on murky growth outlook,Yahoo,"Investing.com -- Raymond James downgraded Danaher Corporation (NYSE:DHR) to ""Market Perform"" from ""Outperform,"" citing concerns over the company's growth trajectory following its fourth-quarter results and guidance that lagged peers."
05-02-2025,"Johnson Controls lifts 2025 profit forecast, names new CEO",Finnhub,"Johnson Controls Internationalnamed Joakim Weidemanis as chief executive officer and liftedits 2025 profit forecast on Wednesday, sending its shares up 13%in early trading. ..."
05-02-2025,"Johnson Controls Names Weidemanis CEO, Logs 1Q Income Growth",Finnhub,"By Rob Curran Johnson Controls named Danaher executive Joakim Weidemanis as chief executive to succeed George Oliver, who last year divulged plans to step down following pressure from activist..."
06-02-2025,Third Point Q4 2024 Investor Letter,SeekingAlpha,"During Q4 2024, Third Point returned 9.1% in the flagship Offshore Fund, and for the 
year returned 24.2%.  Click here to read the full letter. "
06-02-2025,Danaher Corp. stock underperforms Wednesday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Wednesday when compared to competitors
06-02-2025,"Johnson Controls Stock Leads S&P Gainers on New CEO, Solid Q1 Results",Yahoo,Shares of Johnson Controls International surged to lead S&P 500 gainers on Wednesday morning after the company's first-quarter results topped estimates and it announced a new CEO.
07-02-2025,Johnson Controls price target raised to $93 from $86 at RBC Capital,Yahoo,"RBC Capital raised the firm’s price target on Johnson Controls (JCI) to $93 from $86 and keeps a Sector Perform rating on the shares. The company reported a solid 9% operating beat against the firm’s estimate and raised its 2025 guidance, more than flowing through the headline beat, with the “big announcement” also stating that a 13-year Danaher (DHR) veteran Joakim Wedemanis will take the helm as CEO, the analyst tells investors in a research note. Other positives in the quarter include continu"
07-02-2025,Franklin U.S. Focused Growth SMA Q4 2024 Commentary,SeekingAlpha,"During Q4 2024, global stocks were pressured by investor concerns about economic growth, persistent inflation in some regions and the likelihood of further interest rate cuts in 2025."
07-02-2025,Franklin DynaTech SMA Q4 2024 Commentary,SeekingAlpha,"During Q4 2024, global stocks were pressured by investor concerns about economic growth, persistent inflation in some regions and the likelihood of further interest rate cuts in 2025."
08-02-2025,Danaher Corp. stock underperforms Friday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Friday when compared to competitors
09-02-2025,"Danaher Corporation (DHR): ‘Sharp as a Tack People Who’ve Lost Their Way,’ Says Jim Cramer",Yahoo,"We recently published a list of Jim Cramer Discussed These 12 Stocks Recently. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Jim Cramer discussed recently. Jim Cramer, the host of Mad Money, recently examined the latest market trends, highlighting some important themes where […]"
10-02-2025,"Where I'd Put $10,000 Right Now - My Best Dividend Picks For Income And Growth",SeekingAlpha,"If I were investing $10,000 today, I would focus on undervalued essentials, GARP stocks, and opportunities tied to broader economic trends. Click here to read why."
10-02-2025,"Jim Cramer Slams Danaher (DHR): “Bad Quarter, Smug Management”",Yahoo,"We recently published a list of Jim Cramer’s Thoughts on These 9 Stocks. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Jim Cramer discusses. Jim Cramer, host of Mad Money, recently pointed out some unexpected trends in the stock market this year, spotlighting […]"
11-02-2025,Danaher Corp. stock outperforms competitors despite losses on the day,MarketWatch,Danaher Corp. stock outperforms competitors despite losses on the day
12-02-2025,Why Danaher Corporation (DHR) is the Best Medical Device Stock to Buy,Yahoo,"We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other best medical device stocks to buy right now. Overview of the Medical Devices Sector According to a report by […]"
12-02-2025,Invesco Main Street Fund Q4 2024 Commentary,SeekingAlpha,Underperformance mainly resulted from stock selection in health care and communication services. Consumer discretionary led all sectors. Read more here.
13-02-2025,Is Danaher Corporation (DHR) The Best Manufacturing Stock To Buy Now?,Yahoo,"We recently published a list of 10 Best Manufacturing Stocks To Buy Now. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other best manufacturing stocks to buy now. The manufacturing sector stands as a cornerstone of the U.S. economy, significantly contributing to the nation’s gross domestic […]"
13-02-2025,3 Healthcare Stocks Skating on Thin Ice,Yahoo,Personal health and wellness is one of the many secular tailwinds for healthcare companies. But near-term speed bumps have persisted in the wake of COVID-19 as players destocked inventories in 2023 and 2024. This has capped returns as the industry’s six-month gain of 1.2% has lagged the S&P 500’s 12.8% climb.
14-02-2025,All-In: The 23-Stock Six-Figure Dividend Portfolio I'm Betting My Future On,SeekingAlpha,"Reaching 40,000 followers is a milestone! Find out how my portfolio of 23 high-conviction dividend stocks is outperforming the S&P 500 with a value focus."
15-02-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
17-02-2025,Weitz Conservative Allocation Fund Q4 2024 Commentary,SeekingAlpha,The Conservative Allocation Fund's Institutional Class returned -1.52% for the fourth quarter. Read more here.
17-02-2025,Weitz Partners III Opportunity Fund Q4 2024 Commentary,SeekingAlpha,"The Fundâs leading quarterly contributors were Corecard Corp, Visa, Amazon, Alphabet and Global Payments. Read more here."
17-02-2025,Weitz Multi Cap Equity Fund Q4 2024 Commentary,SeekingAlpha,"For the calendar year, the Fundâs Institutional Class returned +15.80% compared to +23.81% for the Russell 3000. Read more here."
17-02-2025,Weitz Large Cap Equity Fund Q4 2024 Commentary,SeekingAlpha,"For the calendar year, the Fundâs Institutional Class returned +12.84%, while the Russell 1000 Index returned +24.51%. Read more here."
17-02-2025,Danaher: Self-Inflicted Pessimism?,SeekingAlpha,Danaher Corp. shows resilience with strong margins and FCF despite challenges. Learn why DHR stock is undervalued and could offer significant upside.
17-02-2025,Mar Vista Global Quality Q4 2024 Commentary,SeekingAlpha,"The MSCI World Net Index climbed 18.7% for the year, marking its second consecutive annual gain above 15%, and capping a remarkable two-year run with a 47% total return."
17-02-2025,Mar Vista U.S. Quality Select Q4 2024 Commentary,SeekingAlpha,"Mar Vistaâs U.S. Quality Select strategy returned +0.39% net-of-fees in the fourth quarter of 2024. The Russell 1000Â® Index and the S&P 500Â® Index returned +2.74% and +2.41%, respectively."
17-02-2025,Mar Vista U.S. Quality Q4 2024 Commentary,SeekingAlpha,"Mar Vistaâs U.S. Quality strategy returned -0.18% net-of-fees in the fourth quarter of 2024. Russell 1000Â® Index and the S&P 500Â® Index returned +2.74% and +2.41%, respectively."
19-02-2025,BNY Mellon Dynamic Value Fund Q4 2024 Commentary,SeekingAlpha,BNY Mellon Dynamic Value Fund (Class A at NAV) returned -1.48% during the fourth quarter of 2024. Read more here.
19-02-2025,Artisan Global Opportunities Fund Q4 2024 Commentary,SeekingAlpha,"The Artisan Global Opportunities Fund portfolio experienced slight weakness in Q4 but delivered a
strong absolute return in 2024. Click here to read the full commentary."
19-02-2025,Tracking Akre Capital Management Portfolio - Q4 2024 Update,SeekingAlpha,
21-02-2025,Madison Sustainable Equity Fund Q4 2024 Investment Strategy Letter,SeekingAlpha,The S&P 500 ended 2024 with a 25% gain for the year. This marks the second consecutive year of gains exceeding 25% and the third such occurrence in the past four years.
21-02-2025,Danaher Announces Appointment of Charles Lamanna to Danaher Board,Yahoo,Danaher Corporation (NYSE: DHR) announced today that it has appointed Charles Lamanna to its Board of Directors and to the Board's Science & Technology Committee.
21-02-2025,Danaher Increases Quarterly Dividend,Yahoo,"Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on April 25, 2025 to holders of record on March 28, 2025. This reflects an 18.5% increase over the previous dividend payment of $0.27."
21-02-2025,Madison Investors Fund Q4 2024 Investment Strategy Letter,SeekingAlpha,"The Madison Investors Fund (class I) decreased 0.4% in the fourth quarter of 2024, compared to the 2.4% increase in the S&P 500 Index. Read more here."
22-02-2025,"Dividend Champion, Contender, And Challenger Highlights: Week Of February 23",SeekingAlpha,"Stay updated with weekly dividend changes for Dividend Champions, Contenders & Challengers. Explore ex-dividend dates, pay dates and more."
22-02-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
23-02-2025,Is Danaher Corporation (DHR)  the Best Scientific Instruments Stock to Buy Right Now?,Yahoo,"We recently published a list of 12 Best Scientific Instruments Stocks to Buy Right Now. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other best scientific instruments stocks to buy right now. The global scientific instruments market has been experiencing steady growth and is expected to […]"
24-02-2025,Here’s What Will Drive Danaher Corporation’s (DHR) Above-Average Growth,Yahoo,"Mar Vista Investment Partners, LLC, an investment management company, released the “Mar Vista U.S. Quality Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The stock market rose in 2024 and carried on through the fourth quarter, as investors welcomed the growing optimism following the presidential election. For the […]"
24-02-2025,Danaher Full Year 2024 Earnings: EPS Misses Expectations,Yahoo,Danaher ( NYSE:DHR ) Full Year 2024 Results Key Financial Results Revenue: US$23.9b (flat on FY 2023). Net income...
25-02-2025,Meridian Hedged Equity Fund Q4 2024 Commentary,SeekingAlpha,
25-02-2025,The Buffett Blueprint - How I'm Building My Own Berkshire Hathaway,SeekingAlpha,"Warren Buffett's recent Berkshire Hathaway letter highlights his disciplined, long-term approach. Find out what we can learn from Buffett's latest insights."
25-02-2025,Hartford Healthcare Fund Q4 2024 Commentary,SeekingAlpha,The Hartford Healthcare Fund (I share) underperformed the S&P Composite 1500 Health Care Index during the quarter. Read more here.
25-02-2025,Tracking Al Gore's Generation Investment Management Portfolio - Q4 2024 Update,SeekingAlpha,"Generation Investment Management reduces portfolio value to $19.17B, adds stakes in GOOG & TTAN, boosts Schwab, MercadoLibre, cuts Amazon & Trimble."
25-02-2025,Danaher Rewards Shareholders With 18.5% Dividend Increase,Yahoo,DHR's measures to consistently reward shareholders through dividends and share buybacks hold promise.
26-02-2025,Danaher to Present at TD Cowen Health Care Conference,Yahoo,"Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Wednesday, March 5, 2025 at 10:30 a.m. ET. The event will be simultaneously webcast and can be accessed on the ""Investors"" section of Danaher's website, www.danaher.com, under the subheading ""Events & Presentations."""
26-02-2025,Danaher Corporation (DHR): Among Bourgeon Capital’s Top Stock Picks,Yahoo,"We recently compiled a list of the Top 12 Stocks to Buy According to Bourgeon Capital. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the other stocks. Bourgeon Capital Management LLC is an investment advisory firm headquartered in Darien, Connecticut. Founded in 1999 by seasoned financial professional […]"
27-02-2025,Jim Cramer to Danaher (DHR) Management: ‘We Are Getting Restless’,Yahoo,"We recently published a list of Jim Cramer’s Latest Calls: Top 10 Stocks. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Jim Cramer discusses. Jim Cramer in a recent program on CNBC discussed the massive tech sell-off on the back of a new […]"
28-02-2025,Danaher Corp. stock outperforms competitors despite losses on the day,MarketWatch,Danaher Corp. stock outperforms competitors despite losses on the day
01-03-2025,Danaher (DHR) Down 7.8% Since Last Earnings Report: Can It Rebound?,Yahoo,Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
04-03-2025,Unpacking Q4 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks,Yahoo,"Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Danaher (NYSE:DHR) and the best and worst performers in the research tools & consumables industry."
05-03-2025,Danaher Corporation (DHR) TD Cowen 45th Annual Health Care Conference Transcript,SeekingAlpha,"Danaher Corporation (NYSE:DHR) TD Cowen 45th Annual Health Care Conference Call March 5, 2025 10:30 AM ETCompany ParticipantsRainer Blair â President and..."
05-03-2025,Tracking Dan Loeb's Third Point Portfolio - Q4 2024 Update,SeekingAlpha,"Dan Loeb's Third Point 13F reveals portfolio shifts, new stakes, and top holdings. Portfolio value slightly increased to $7.44B. Read more on the portfolio here."
06-03-2025,Fidelity Equity-Income Fund Q4 2024 Review,SeekingAlpha,
07-03-2025,ClearBridge Large Cap Value ESG Strategy Q4 2024 Commentary,SeekingAlpha,The ClearBridge Large Cap Value ESG Strategy outperformed its Russell 1000 Value Index benchmark during the fourth quarter. Click here to read the full commentary.
07-03-2025,ClearBridge Sustainability Leaders Strategy Q4 2024 Commentary,SeekingAlpha,The ClearBridge Sustainability Leaders Strategy underperformed its Russell 3000 Index benchmark in the fourth quarter. Click here to read the full commentary. 
07-03-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
08-03-2025,Why Danaher Corporation (DHR) Is Plunging So Far in 2025?,Yahoo,"We recently published a list of Why These 15 Big-Cap Stocks Are Plunging So Far in 2025. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other big-cap stocks that are plunging so far in 2025. The market has been reversing its gains earlier in the year, […]"
08-03-2025,Danaher Corp. stock underperforms Friday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Friday when compared to competitors
10-03-2025,"Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System",Yahoo,"Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the new DxC 500i Clinical Analyzer, an integrated clinical chemistry and immunoassay analyzer, received 510(k) clearance from the U.S. Food and Drug Administration. The DxC 500i combines advanced technology with an intuitive user interface, ensuring that laboratories of all sizes can meet the growing demands of modern healthcare. With throughput of up to 800 clinical chemistry tests per hour and 100 immunoassay test"
11-03-2025,Here's Why You Should Avoid Betting on Danaher Stock Right Now,Yahoo,Persistent softness in the Life Sciences segment weighs on DHR's performance. An increase in operating expenses is an added concern.
11-03-2025,Invesco Charter Fund Q4 2024 Commentary,SeekingAlpha,
11-03-2025,Invesco Global Core Equity Fund Q4 2024 Commentary,SeekingAlpha,"Global equity returns were mixed in the fourth quarter, with developed equities outperforming emerging market equities."
11-03-2025,"Danaher (DHR): Buy, Sell, or Hold Post Q4 Earnings?",Yahoo,Shareholders of Danaher would probably like to forget the past six months even happened. The stock dropped 23.9% and now trades at $207. This might have investors contemplating their next move.
11-03-2025,GE Vernova: A Good Buy Post The Recent Correction,SeekingAlpha,GE Vernova is poised for strong revenue and earnings growth due to a solid backlog. Read why I maintain my buy rating on GEV stock.
11-03-2025,Danaher Corp. stock underperforms Monday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Monday when compared to competitors
12-03-2025,Here’s Why Danaher Corporation Corp (DHR) Fell in Q4,Yahoo,"Meridian Funds, managed by ArrowMark Partners, released its “Meridian Hedged Equity Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The direction of interest rates, inflation, and the outcome of the US election all had a significant impact on the markets throughout the quarter. In the quarter, the fund […]"
12-03-2025,Fidelity Select Health Care Portfolio Q4 2024 Review,SeekingAlpha,"Health care stocks returned -9.75% in the final quarter of 2024, according to the MSCI U.S. IMI Health Care 25/50 Index, widely lagging the 2.41% gain of the broad-based S&P 500Â® index."
13-03-2025,Danaher : Scaling innovation through investment partnerships,Finnhub,"We have two main investment vehicles right now. The first is the investment partnership, as I described with Innovaccer, where in addition to capital, the company and Danaher form a partnership. These..."
14-03-2025,Honeywell's Planned Spinoff And What It Means Amid Macro Volatility,SeekingAlpha,"After a slew of generally successful spinoffs elsewhere in the market, Honeywell looks to split into three units. Read more here."
15-03-2025,"Chipotle upgraded, Charter initiated: Wall Street’s top analyst calls",Yahoo,"The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Loop Capital upgraded Chipotle (CMG) to Buy from Neutral with a price target of $65, up from $58. There is the potential for at least 7.0%-8.0% upside to the current consensus EPS estimate of $1.30 for 2025 if comparable sales continue to beat expectations over the course of the current year, the firm"
15-03-2025,Veralto: Adding To Its Reputation,SeekingAlpha,Veralto delivers solid growth but at demanding multiples. Find out why VLTO stock is still too rich for a 'buy' despite a promising outlook for 2025.
15-03-2025,Stifel Upgrades Danaher (DHR),Fintel,
15-03-2025,"Danaher Stock Has Fallen Far Enough. Buy It Now, Says Analyst.",Yahoo,"FEATURE   Danaher stock gained after picking up a bullish call from Wall Street.  Valuation normalization is the reason, and after a painful few months, the stock looks attractive again.  Shares of the life-sciences company rose 3."
20-03-2025,Lazard US Equity Focus Portfolio Q4 2024 Commentary,SeekingAlpha,"The US equity market advanced in the fourth quarter, as investors responded to Donald Trumpâs decisive victory. Click here to read the full commentary. "
20-03-2025,Invesco Health Care Fund Q4 2024 Commentary,SeekingAlpha,"Stock selection in life science tools & services, pharmaceuticals and distributors detracted from relative performance, as did an overweight in health care facilities."
20-03-2025,Danaher Corp. stock underperforms Wednesday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Wednesday when compared to competitors
21-03-2025,Lazard US Sustainable Equity Portfolio Q4 2024 Commentary,SeekingAlpha,"In Q4 2024, the Lazard US Sustainable Equity Portfolio underperformed the return for the S&P 500 Index. Click here to read the full commentary. "
21-03-2025,Danaher Schedules First Quarter 2025 Earnings Conference Call,Yahoo,"Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the first quarter 2025 on Tuesday, April 22, 2025 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations."
22-03-2025,Danaher: Near 5-Year Low Is A Great Entry Point,SeekingAlpha,Discover why Danaher Corporation's 5-year low presents a potential growth opportunity. Explore its strong fundamentals & 10%-13% EPS growth forecast.
22-03-2025,"Dividend Champion, Contender, And Challenger Highlights: Week Of March 23",SeekingAlpha,"Stay updated with weekly dividend activity for Champions, Contenders, and Challengers. Learn about changes, ex-dividend dates, and upcoming pay dates."
23-03-2025,Danaher Corporation (DHR): Among Stocks Wall Street Is Calling Bullish Amid Market Turmoil,Yahoo,"We recently published a list of 10 Stocks Wall Street Is Calling Bullish Amid Market Turmoil. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Wall Street is calling bullish amid market turmoil. The S&P 500 is down 8.6% in a month while the […]"
25-03-2025,Why Danaher Corporation (DHR) is Among the Best Diagnostics Stocks to Invest in Right Now,Yahoo,"We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the other best diagnostics stocks to invest in right now. Overview of the Clinical Diagnostics Market According to a report by Mordor […]"
25-03-2025,"8 Upcoming Dividend Increases, Including A King",SeekingAlpha,"Discover 8 companies with dividend hikes, 4 exceeding 10%. Learn how consistent growth and smart strategies can boost your portfolio."
26-03-2025,Danaher : 2025 Proxy Statement,Finnhub,Notice of 2025 Annual Meeting of Shareholders Items of Business 1 2 3 4 To elect the thirteen directors named in the attached Proxy...
27-03-2025,Trump auto tariffs: Wall Street reacts as stocks slide,Yahoo,Automakers get walloped by new Trump tariffs.
27-03-2025,ClearBridge Sustainability Leaders Fund Q4 2024 Commentary,SeekingAlpha,
29-03-2025,Danaher Corp. stock outperforms competitors despite losses on the day,MarketWatch,Danaher Corp. stock outperforms competitors despite losses on the day
30-03-2025,Is Danaher Corporation (DHR) the Top Stock to Buy According to Akre Capital Management?,Yahoo,"We recently published a list of Top 10 Stocks to Buy According to Akre Capital Management. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other top stocks to buy according to Akre Capital Management. Akre Capital Management follows a disciplined investment philosophy centered around identifying exceptional businesses […]"
30-03-2025,Putnam Large Cap Growth Fund Q4 2024 Commentary,SeekingAlpha,"US equities had another positive quarter, with the S&P 500 Index returning 2.41% and our primary benchmark, the Russell 1000 Growth Index, returning 7.07%."
31-03-2025,John Hancock U.S. Global Leaders Growth Fund Q4 2024 Commentary,SeekingAlpha,
31-03-2025,Danaher Corporation: A Mixed Bag Of Strength And Stagnation,SeekingAlpha,Danaher Corporation incorporates science and technology and has a market cap of $150B.
31-03-2025,"Danaher: Some Near-Term Headwinds, But Good Long-Term Prospects And Low Valuations",SeekingAlpha,"Danaher has good medium to long-term revenue and margin growth prospects, and the valuation is lower than historical levels. Read why DHR stock is a Buy."
01-04-2025,Danaher: Operational Excellence Meets Cyclical Pause - A Hold Amid Recovery Prospects,SeekingAlpha,
02-04-2025,3 Wide-Moat Dividend Stars For A Championship Portfolio,SeekingAlpha,
02-04-2025,Lord Abbett Dividend Growth Fund Q4 2024 Commentary,SeekingAlpha,"The Fund returned -0.25%, reflecting performance at the net asset value of Class I shares with all distributions reinvested for the quarter ended September 30, 2024."
02-04-2025,"Top Analyst Reports for Amazon, Oracle & Merck",Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc. (AMZN), Oracle Corp. (ORCL) and Merck & Co., Inc. (MRK)."
02-04-2025,Danaher Corporation (DHR): One of the Best Healthcare Stocks to Buy According to Billionaires,Yahoo,"We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other best healthcare stocks to invest in. Healthcare stocks experienced a challenging year in 2024, lagging behind high-growth sectors like tech and AI. […]"
03-04-2025,Is Danaher Corporation (DHR) a Well-Positioned Company Heading into 2025?,Yahoo,"Artisan Partners, an investment management company, released its “Artisan Global Opportunities Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. US equities experienced significant gains in Q4, showcasing a strong year. The portfolio showed slight weakness in Q4 but posted a strong absolute return in 2024. In the fourth […]"
03-04-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
04-04-2025,Danaher Gains From Strength in the Diagnostics Unit Amid Headwinds,Yahoo,"DHR is poised to gain from strength in the clinical diagnostics business, the Abcam buyout and shareholder-friendly policies. Softness in Life Sciences and Biotechnology units remains a concern."
04-04-2025,Andvari Associates Q1 2025 Letter,SeekingAlpha,"For Q1 2025, Andvari is up 7.2% net of fees while the SPDR S&P 500 ETF (SPY) is down 4.3%. Click here to read the full letter. "
04-04-2025,Danaher Corp. stock outperforms competitors despite losses on the day,MarketWatch,Danaher Corp. stock outperforms competitors despite losses on the day
05-04-2025,Danaher Corp. stock underperforms Friday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Friday when compared to competitors
06-04-2025,Danaher (NYSE:DHR) Faces 12% Weekly Drop Amid Trade Tension Concerns,Yahoo,"Last week, the market was shaken by significant events, including President Trump's announcement of sweeping tariffs, sparking fears of a global economic downturn. Danaher (NYSE:DHR) experienced an 11% decline over the same period, paralleling the broader market turmoil. The drastic stock fluctuations were largely attributed to jittery investor sentiment, compounded by the tariffs and resulting trade tensions. As the market tumbled, the Nasdaq also entered bear market territory. Danaher's..."
07-04-2025,Tariffs And Tactics: Agilent's Path Through Trade Disruption,SeekingAlpha,
09-04-2025,Oxford Nanopore teams up with Danaher subsidiary Cepheid,Finnhub,Oxford Nanopore Technologies PLC on Wednesday announced a collaboration aimed at advancing automated sequencing-based solutions.The Oxford-based specialist in DNA and RNA sequencing technologies...
09-04-2025,Danaher Corporation (DHR): Among Stocks with Buy Ratings that Hedge Funds Love,Yahoo,"We recently published a list of 15 Stocks with Buy Ratings that Hedge Funds Love. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks with buy ratings that hedge funds love. The U.S. stock market has been in chaos ever since President Trump announced his […]"
09-04-2025,Danaher Corp. stock outperforms competitors despite losses on the day,MarketWatch,Danaher Corp. stock outperforms competitors despite losses on the day
10-04-2025,Here’s How Danaher Corporation (DHR) Benefits from Switching Costs,Yahoo,"Andvari Associates, an investment management firm, released its first-quarter 2025 investor letter. A copy of the letter can be downloaded here. In the first quarter the fund returned 7.2% net of fees compared to the SPDR S&P 500 ETF’s 4.3% decline. In addition, you can check the fund’s top 5 holdings to find out its […]"
10-04-2025,Barclays Upgrades Danaher (DHR),Fintel,
11-04-2025,Jim Cramer Calls Out Danaher (DHR) CEO: “Time to Step Up or Step Aside”,Yahoo,"We recently published a list of Jim Cramer Talked About These 8 Stocks. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Jim Cramer discusses. On Friday, Jim Cramer, the host of Mad Money, expressed concern over President Donald Trump’s focus on the long-term […]"
11-04-2025,Akre Focus Fund Q1 2025 Commentary,SeekingAlpha,
11-04-2025,Danaher Corp. stock underperforms Thursday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Thursday when compared to competitors
12-04-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
14-04-2025,Is Danaher Corporation (DHR) the Best Medical Stock to Buy According to Billionaires?,Yahoo,"We recently published a list of 10 Best Medical Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other best medical stocks to buy according to billionaires. Why are Healthcare Stocks Under Pressure? Some experts view medical, healthcare, and big pharma […]"
15-04-2025,Danaher (DHR) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release,Yahoo,Danaher (DHR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
15-04-2025,Parnassus Core Select ETF Q1 2025 Commentary,SeekingAlpha,
15-04-2025,Danaher Corp. stock underperforms Monday when compared to competitors despite daily gains,MarketWatch,Danaher Corp. stock underperforms Monday when compared to competitors despite daily gains
16-04-2025,"Exploring Analyst Estimates for Danaher (DHR) Q1 Earnings, Beyond Revenue and EPS",Yahoo,"Besides Wall Street's top -and-bottom-line estimates for Danaher (DHR), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025."
17-04-2025,2 of Wall Street’s Favorite Stocks with Competitive Advantages and 1 to Be Wary Of,Yahoo,"Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts."
18-04-2025,Danaher Corp. stock outperforms competitors despite losses on the day,MarketWatch,Danaher Corp. stock outperforms competitors despite losses on the day
19-04-2025,"Dividend Champion, Contender, And Challenger Highlights: Week Of April 20",SeekingAlpha,
21-04-2025,Danaher Gears Up to Post Q1 Earnings: Is a Beat in Store?,Yahoo,"DHR's first-quarter earnings are likely to have been aided by strength in the Biotechnology segment. However, weakness in the Diagnostics and Life Sciences segments are expected to have hurt."
21-04-2025,Danaher (DHR) To Report Earnings Tomorrow: Here Is What To Expect,Yahoo,Diversified science and technology company Danaher (NYSE:DHR) will be announcing earnings results tomorrow morning. Here’s what to look for.
22-04-2025,Danaher Fiscal First-Quarter Results Top Views; Forecasts Core Revenue Growth,Yahoo,"Danaher (DHR) on Tuesday reported better-than-expected fiscal first-quarter results, while the medic"
22-04-2025,Danaher (DHR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates,Yahoo,"The headline numbers for Danaher (DHR) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals."
22-04-2025,Danaher sees net income and revenue decline in first quarter,Fintel,
22-04-2025,Danaher Corporation 2025 Q1 - Results - Earnings Call Presentation,SeekingAlpha,
22-04-2025,Danaher (DHR) Surpasses Q1 Earnings and Revenue Estimates,Yahoo,"Danaher (DHR) delivered earnings and revenue surprises of 16.05% and 3.34%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?"
22-04-2025,Danaher Corporation (DHR) Q1 2025 Earnings Call Transcript,SeekingAlpha,
22-04-2025,"Danaher (NYSE:DHR) Surprises With Q1 Sales, Next Quarter’s Sales Guidance is Optimistic",Yahoo,"Diversified science and technology company Danaher (NYSE:DHR) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $5.74 billion. Guidance for next quarter’s revenue was better than expected at $5.92 billion at the midpoint, 1.9% above analysts’ estimates. Its non-GAAP profit of $1.88 per share was 14.4% above analysts’ consensus estimates."
22-04-2025,Danaher: Q1 Earnings Snapshot,Yahoo,WASHINGTON (AP) — Danaher Corp. DHR) on Tuesday reported first-quarter profit of $954 million. The Washington-based company said it had profit of $1.32 per share.
22-04-2025,Danaher Reports First Quarter 2025 Results,Yahoo,"Danaher Corporation (NYSE: DHR) (the ""Company"") today announced results for the quarter ended March 28, 2025."
22-04-2025,Earnings season is off to a lackluster start: DataTrek,MarketWatch,Earnings season is off to a lackluster start: DataTrek
22-04-2025,Danaher 1Q Results Decline But Top Estimates,Finnhub,"By Denny Jacob Danaher posted improved results across key metrics in its latest quarter, which it attributed to momentum in its bioprocessing unit and demand above expectations in its molecular..."
22-04-2025,Tesla kicks off Mag 7 results as earnings season picks up speed,MarketWatch,Tesla kicks off Mag 7 results as earnings season picks up speed
22-04-2025,Danaher Corp. stock outperforms competitors despite losses on the day,MarketWatch,Danaher Corp. stock outperforms competitors despite losses on the day
23-04-2025,BLCO or DHR: Which Is the Better Value Stock Right Now?,Yahoo,BLCO vs. DHR: Which Stock Is the Better Value Option?
23-04-2025,Danaher First Quarter 2025 Earnings: Beats Expectations,Yahoo,Danaher ( NYSE:DHR ) First Quarter 2025 Results Key Financial Results Revenue: US$5.74b (flat on 1Q 2024). Net income...
23-04-2025,Danaher Corp (DHR) Q1 2025 Earnings Call Highlights: Strong Bioprocessing Growth Amidst Mixed ...,Yahoo,"Danaher Corp (DHR) reports robust bioprocessing growth and improved profitability, despite challenges in Life Sciences and Diagnostics segments."
23-04-2025,Q1 2025 Danaher Corp Earnings Call,Yahoo,Q1 2025 Danaher Corp Earnings Call
23-04-2025,DHR Q1 Earnings: Bioprocessing Momentum and Tariff Strategy Drive Guidance Above Expectations,Yahoo,"Diversified science and technology company Danaher (NYSE:DHR) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $5.74 billion. Guidance for next quarter’s revenue was better than expected at $5.92 billion at the midpoint, 1.4% above analysts’ estimates. Its non-GAAP profit of $1.88 per share was 14.4% above analysts’ consensus estimates."
23-04-2025,S&P Behemoth Danaher Surges On Plans To Navigate Pharma-Tied Tariffs,Yahoo,"Danaher stock jumped Tuesday after the medical powerhouse delivered a ""solid"" first-quarter report and maintained its outlook for the year."
23-04-2025,"Danaher (DHR) Stock Trades Up, Here Is Why",Yahoo,"Shares of diversified science and technology company Danaher (NYSE:DHR) jumped 6.6% in the afternoon session after the company reported impressive first quarter 2025 results, which beat analysts' organic revenue and EPS expectations. Revenue was flat year-over-year on a core basis, which masked a 7% gain in biotech and a modest decline in life sciences, revealing the uneven recovery across business lines. Looking ahead, sales guidance for the next quarter was ahead, while full year EPS guidance"
23-04-2025,"Danaher Q1 Earnings Beat Estimates, Life Sciences Sales Down Y/Y",Yahoo,"DHR's first-quarter sales decrease 1% year over year, due to the lackluster performance of its Life Sciences and Biotechnology segments."
24-04-2025,"Danaher predicts $350M tariff hit, moves to mitigate impact on profits",Yahoo,"The company is planning manufacturing footprint changes, supply chain adjustments, surcharges and cost cutting to limit the impact of the tariffs."
24-04-2025,Danaher price target lowered to $240 from $260 at Goldman Sachs,Yahoo,"Goldman Sachs analyst Matthew Sykes lowered the firm’s price target on Danaher (DHR) to $240 from $260 but keeps a Buy rating on the shares after its Q1 results. The company’s Bioprocessing business continues to improve, and the current tariff headwind appears manageable, the analyst tells investors in a research note. Despite the top and bottom line beat in the quarter however, there is still merit in the prudent approach with Danaher maintaining prior FY25 guidance given all the moving parts a"
24-04-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
24-04-2025,Danaher Corporation (DHR): Among Top Stocks in Bill Gates’ Portfolio with Huge Upside Potential,Yahoo,"We recently published a list of Bill Gates’ 10 Stock Positions with Huge Upside Potential. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other top stocks in Bill Gates’ portfolio with huge upside potential. Bill Gates became the youngest billionaire back in 1987 when he took […]"
27-04-2025,Baron Health Care Fund Q1 2025 Shareholder Letter,SeekingAlpha,
28-04-2025,"Revvity joins peers Thermo Fisher, Danaher in tariff warning, maintains profit outlook",Finnhub,"Medical equipment maker Revvity on Monday joined larger peers in warning about the impact of tariffs imposed by the U.S. President Donald Trump's administration, but maintained its annual profit..."
28-04-2025,Danaher Corporation (DHR): Among Billionaire Ken Fisher’s Healthcare Stock Picks with Massive Upside Potential,Yahoo,"We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other billionaire Ken Fisher’s healthcare stock picks with massive upside potential. The healthcare industry, an essential component of global well-being and […]"
29-04-2025,Kytopen and Aldevron Expedite Cell Therapy Manufacturing Through Their Collaborative CRISPR-mediated Cellular Engineering Workflow,Yahoo,"Kytopen Corp., a leader in providing non-viral, continuous flow cellular engineering technologies and Aldevron, a leading global manufacturer serving organizations in the gene editing, mRNA vaccine and therapeutics, viral gene therapy, and modified gene therapy spaces; today announced, a joint marketing agreement aimed at enhancing the workflow solutions for cell therapy manufacturers. The collaboration will focus on the joint promotion of the synergies achieved by combining the Aldveron Nanopla"
29-04-2025,Jim Cramer on Danaher Corporation (DHR): From Best to Worst Amid China Struggles,Yahoo,"We recently published a list of Jim Cramer Talks About Elon Musk & Discusses These 11 Stocks. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Jim Cramer recently discussed. In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer commented that […]"
29-04-2025,Baron Health Care Fund Q1 2025 Top Contributors And Detractors,SeekingAlpha,Baron Health Care Fund declined 2.54% in Q1 2025. Who were the leaders and laggards? Click here to find out. 
30-04-2025,The Davenport Core Leaders Fund Q1 2025 Commentary,SeekingAlpha,"The Davenport Core Leaders Fund declined 3.48% in Q1 2025, although it did exceed its benchmark. Click here to read the full commentary. "
30-04-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
02-05-2025,Third Point Investors says fund down in first quarter amid tariffs,Finnhub,Third Point Investors Ltd on Friday said its flagship Offshore Fund declined 3.7% in the first quarter as US tariff announcements and the prospect of a global trade war weighed on markets.The feeder...
02-05-2025,Third Point Q1 2025 Investor Letter,SeekingAlpha,"During the First Quarter of 2025, Third Point returned -3.7% in the flagship Offshore Fund. Click here to read the full letter. "
02-05-2025,Danaher: Q1 Beat Fails To Trigger Guidance Upgrade,SeekingAlpha,"Danaher delivered better-than-expected Q1 2025 results, driven by strong performance in biotechnology and molecular diagnostics. Find out why DHR stock is a Buy."
02-05-2025,Danaher Corporation (DHR): Among Charles Akre’s and John Neff’s Stock Picks With Huge Upside Potential,Yahoo,"We recently published an article titled Charles Akre’s and John Neff’s 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the other stocks with huge upside potential according to Charles Akre and John Neff. The current market environment of the […]"
02-05-2025,Danaher Corp. stock outperforms competitors despite losses on the day,MarketWatch,Danaher Corp. stock outperforms competitors despite losses on the day
03-05-2025,"Danaher Corp. stock rises Friday, still underperforms market",MarketWatch,"Danaher Corp. stock rises Friday, still underperforms market"
06-05-2025,"Danaher: A Capital Intensive Business Offering Low Risk, Low Reward Opportunity",SeekingAlpha,"Danaher Corp.'s intrinsic value shows 14% upside, but challenges like high debt & low growth reduce its investment appeal."
07-05-2025,Fidelity Select Health Care Portfolio Q1 2025 Commentary,SeekingAlpha,"For Q1 2025, the Fidelity Select Health Care Portfolio returned -1.03%, underperforming the MSCI health care index. Click here to read the full commentary. "
07-05-2025,Danaher Announces Quarterly Dividend,Yahoo,"Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on July 25, 2025 to holders of record on June 27, 2025."
07-05-2025,Danaher Corp. stock underperforms Tuesday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Tuesday when compared to competitors
08-05-2025,Danaher to Present at Bank of America Securities Healthcare Conference,Yahoo,"Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the at the Bank of America Securities Health Care Conference in Las Vegas, Nevada on Thursday, May 15, 2025 at 10:00 a.m. PT. The event will be simultaneously webcast on www.danaher.com."
08-05-2025,Danaher (NYSE:DHR) Declares US$0.32 Quarterly Dividend Payment,Yahoo,"Danaher (NYSE:DHR) recently affirmed a quarterly dividend of $0.32 per share, set for payout in July. Over the past month, the company's share price rose by 5%, reflecting a positive market response amid mixed broader market trends, as the Dow Jones and other indices showed varied movements tied to economic policies and earnings reports. Despite a decline in Q1 earnings and a buyback update, the dividend announcement likely added favorable sentiment towards Danaher's stock. This period's..."
08-05-2025,Danaher Corporation (DHR): A Bull Case Theory,Yahoo,"We came across a bullish thesis on Danaher Corporation (DHR) on Substack by Best Anchor Stocks. In this article, we will summarize the bulls’ thesis on DHR. Danaher Corporation (DHR)’s share was trading at $196.71 as of May 1st. DHR’s trailing and forward P/E were 38.12 and 25.64 respectively according to Yahoo Finance. Danaher recently reported a […]"
08-05-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
09-05-2025,CVS vs. DHR: Which Stock Is the Better Value Option?,Yahoo,CVS vs. DHR: Which Stock Is the Better Value Option?
09-05-2025,"Revvity: Despite Facing Multiple Headwinds, Shares Are A Buy",SeekingAlpha,Discover why Revvity remains a 'buy' despite biotech funding cuts and sector challenges.
09-05-2025,Is Danaher Corporation (DHR) the Best Medical Device Stock to Buy Now?,Yahoo,"We recently published a list of 11 Best Medical Device Stocks to Buy Now. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other best medical device stocks to buy now. Trump’s Tariffs Are Dividing the Medical Community On April 16, CNBC reported that Trump’s tariffs are […]"
09-05-2025,1 S&P 500 Stock with Competitive Advantages and 2 to Keep Off Your Radar,Yahoo,"The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition."
09-05-2025,Spotting Winners: Sotera Health Company (NASDAQ:SHC) And Research Tools & Consumables Stocks In Q1,Yahoo,"The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how research tools & consumables stocks fared in Q1, starting with Sotera Health Company (NASDAQ:SHC)."
09-05-2025,"From Apple to GM, Tariffs to Cost Companies Tens of Billions",Yahoo,"(Bloomberg) -- From Apple Inc. to General Motors Co., corporate America is bracing for tens of billions of dollars in damages from Trump’s trade war — and that’s before most affected goods have landed.Most Read from BloombergIs Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic?As Trump Reshapes Housing Policy, Renters Face Rollback of RightsVail to Borrow Muni Debt to Ease Ski Resort Town Housing CrunchNYC Warns of 17% Drop in Foreign Tourists Due to Trump PoliciesLA Mayor Credits T"
10-05-2025,Danaher Corporation (DHR): Among Billionaire Lei Zhang’s Stock Picks with Huge Upside Potential,Yahoo,"We recently published a list of Billionaire Lei Zhang’s 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other billionaire Lei Zhang’s stock picks with huge upside potential. Lei Zhang and Hillhouse Capital: Quiet Power in Asian Investing Lei Zhang, […]"
10-05-2025,Danaher Corp. stock underperforms Friday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Friday when compared to competitors
12-05-2025,Q1 Earnings Highs And Lows: Avantor (NYSE:AVTR) Vs The Rest Of The Research Tools & Consumables Stocks,Yahoo,"Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Avantor (NYSE:AVTR) and the best and worst performers in the research tools & consumables industry."
13-05-2025,Danaher Corp. stock underperforms Monday when compared to competitors despite daily gains,MarketWatch,Danaher Corp. stock underperforms Monday when compared to competitors despite daily gains
14-05-2025,Danaher Corp. stock underperforms Tuesday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Tuesday when compared to competitors
15-05-2025,Danaher Corporation (DHR) BofA Securities 2025 Healthcare Conference (Transcript),SeekingAlpha,
15-05-2025,"Transcript : Danaher Corporation Presents at BofA Securities 2025 Healthcare Conference, May-15-2025 10",Finnhub,"Presenter SpeechMichael Ryskin I'm excited to host our next session. We're joined by Danaher. I'm joined by Rainer Blair, CEO. Rainer thanks so much for being here.Presenter SpeechRainer Blair Good..."
15-05-2025,Q1 Research Tools & Consumables Earnings: Danaher (NYSE:DHR) Impresses,Yahoo,"Looking back on research tools & consumables stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Danaher (NYSE:DHR) and its peers."
15-05-2025,Tracking Akre Capital Management Portfolio - Q1 2025 Update,SeekingAlpha,Akre Capitalâs Q1 2025 13F portfolio value declined ~10% to $10.4B. Click here to read more about the portfolio's stake increases and decreases.
15-05-2025,Danaher Corp. stock outperforms competitors despite losses on the day,MarketWatch,Danaher Corp. stock outperforms competitors despite losses on the day
16-05-2025,Daniel Loeb's Strategic Moves: Danaher Corp Exit Impacts Portfolio by -5.87%,Yahoo,Exploring the Latest 13F Filing and Investment Strategies
16-05-2025,Aldevron and Integrated DNA Technologies Manufacture World’s First mRNA-based Personalized CRISPR Therapy,Yahoo,"FARGO, N.D. & CORALVILLE, Iowa, May 15, 2025--N of 1 therapy uniquely developed for infant with life-threatening rare metabolic disorder in six months by Aldevron and Integrated DNA Technologies."
17-05-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
19-05-2025,Greenhaven Road Capital Main Fund Q1 2025 Investor Letter,SeekingAlpha,The Greenhaven Road Capital Main Fund returned approximately â12% net of fees and expenses in the first quarter. Click here to read the full fund letter. 
22-05-2025,Why Is Danaher (DHR) Down 4.8% Since Last Earnings Report?,Yahoo,Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
22-05-2025,Here's Why Investors Should Consider Retaining Danaher Stock Now,Yahoo,"DHR gains from strength across its businesses, acquired assets and shareholder-friendly policies. High long-term debt remains concerning."
22-05-2025,BNY Mellon Dynamic Value Fund Q1 2025 Commentary,SeekingAlpha,BNY Mellon Dynamic Value Fund (Class A at NAV) returned 2.63% during the first quarter of 2025.
22-05-2025,"Danaher, Illumina, Globalstar, and Insperity Shares Plummet, What You Need To Know",Yahoo,"A number of stocks fell in the afternoon session after the major indices fell further in the afternoon (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that could worsen the already wide US fiscal deficit. A poor auction for 20-year U.S. Treasury bonds further raised concerns, as weak demand implies investors are becoming more cautious about holding long-dated U.S. debt."
22-05-2025,Danaher Corp. stock underperforms Wednesday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Wednesday when compared to competitors
23-05-2025,Was Jim Cramer Right About Danaher Corporation (DHR)?,Yahoo,"We recently published a list of Was Jim Cramer Right About These 12 Stocks? In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other stocks that Jim Cramer discusses. Back in 2024, on May 15, Mad Money’s Jim Cramer discussed how some long-time outperformers were being overlooked, […]"
24-05-2025,Danaher Corp. stock outperforms competitors despite losses on the day,MarketWatch,Danaher Corp. stock outperforms competitors despite losses on the day
26-05-2025,CVS or DHR: Which Is the Better Value Stock Right Now?,Yahoo,CVS vs. DHR: Which Stock Is the Better Value Option?
26-05-2025,Tracking Al Gore's Generation Investment Management Portfolio - Q1 2025 Update,SeekingAlpha,
28-05-2025,Research Tools & Consumables Stocks Q1 Recap: Benchmarking Mettler-Toledo (NYSE:MTD),Yahoo,"Looking back on research tools & consumables stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Mettler-Toledo (NYSE:MTD) and its peers."
28-05-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
29-05-2025,RGA Investment Advisors Q1 2025 Investment Commentary,SeekingAlpha,"In their Q1 2025 RGA Investment Advisors discuss navigating market uncertainty, AI, and Life Sciences. Click here to read the full fund letter."
30-05-2025,Danaher Partners With AstraZeneca to Support Precision Medicine,Yahoo,"DHR and AstraZeneca team up to develop AI-powered diagnostics, aiming to boost precision medicine by improving patient selection and making advanced tests accessible worldwide."
30-05-2025,Danaher and AstraZeneca to develop diagnostic tools and tests,Yahoo,"The focus will initially be on creating computational and digital pathology products, as well as AI-assisted algorithms."
30-05-2025,Weitz Conservative Allocation Fund Q1 2025 Commentary,SeekingAlpha,The Conservative Allocation Fund's Institutional Class returned -0.24% for the first quarter compared to +1.95% for the Morningstar Moderately Conservative...
30-05-2025,Weitz Partners III Opportunity Fund Q1 2025 Commentary,SeekingAlpha,"The Partners III Opportunity Fundâs Institutional Class returned -0.45% for the first quarter of 2025, comparing favorably to the Russell 3000 Indexâs return of -4.72%."
30-05-2025,Weitz Multi Cap Equity Fund Q1 2025 Commentary,SeekingAlpha,"The Multi Cap Equity Fundâs Institutional Class returned +0.81% for the quarter, comparing favorably to the Russell 3000 Indexâs loss of -4.72%."
30-05-2025,Weitz Large Cap Equity Fund Q1 2025 Commentary,SeekingAlpha,
30-05-2025,Danaher partners with AstraZeneca to develop AI diagnostics,Finnhub,"Danaher Corp on Thursday said it has entered a partnership with AstraZeneca PLC to develop and commercialise tools and tests for precision medicine treatments, including artificial intelligence..."
30-05-2025,Danaher Corporation (DHR) Launches Partnership with AstraZeneca PLC (AZN) to Scale Next-Gen Precision Medicine Tests,Yahoo,"Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the development and commercialization of advanced diagnostic tools aimed at expanding precision medicine. Leveraging DHR’s newly launched Centers for Enabling Precision Medicine, the collaboration will focus on creating AI-powered diagnostics to help clinicians better identify which patients are most likely to […]"
30-05-2025,Madison Large Cap Fund Q1 2025 Investment Strategy Letter,SeekingAlpha,
30-05-2025,Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine,Yahoo,"Danaher Corporation (NYSE: DHR) (""Danaher""), a global science and technology innovator, announced today the launch of a partnership with AstraZeneca (LSE/STO/Nasdaq: AZN) to develop and commercialize novel diagnostic tools and tests intended to help clinicians better determine which patients would most benefit from precision medicine treatments."
31-05-2025,Danaher (NYSE:DHR) Partners With AstraZeneca To Advance Precision Medicine Diagnostics,Yahoo,"Danaher (NYSE:DHR) recently announced a collaboration with AstraZeneca to develop innovative diagnostic tools, possibly adding momentum to its 1.59% share price increase over the past week. However, this uptick aligns with the broader market gain of 1.2%, suggesting the partnership likely provided additional support rather than being a sole driver. Broader market sentiment was influenced by global trade developments and economic data indicating moderated inflation. Despite Danaher's ongoing..."
02-06-2025,SCIEX Sets a New Standard in Accurate Mass Quantitation With the ZenoTOF 8600 System and New Software Collaborations,Yahoo,"MARLBOROUGH, Mass., June 02, 2025--At ASMS 2025, SCIEX launches the ZenoTOF 8600 system, setting a new standard in accurate mass quantitation."
02-06-2025,Software Launches for SCIEX OS Ecosystem to Help Scientists Accelerate Discoveries and Streamline Lab Operations,Yahoo,"MARLBOROUGH, Mass., June 02, 2025--SCIEX announces three software ecosystem enhancements at ASMS, supporting the theme that ""all science is data science now."""
02-06-2025,SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement,Yahoo,"MARLBOROUGH, Mass., June 02, 2025--SCIEX and Evosep expand access to standardized proteomics for Pharma and Biotech with new reseller agreement."
02-06-2025,Software Launches For Sciex Os Ecosystem,Finnhub,Danaher Corp: * SOFTWARE LAUNCHES FOR SCIEX OS ECOSYSTEM TO HELPSCIENTISTSACCELERATE DISCOVERIES AND STREAMLINE LAB OPERATIONSSource text:Further company coverage: ...
02-06-2025,1 Cash-Producing Stock with Exciting Potential and 2 to Question,Yahoo,"A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand."
02-06-2025,Q1 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks,Yahoo,"Wrapping up Q1 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Thermo Fisher (NYSE:TMO) and its peers."
03-06-2025,Spotting Winners: Bio-Techne (NASDAQ:TECH) And Research Tools & Consumables Stocks In Q1,Yahoo,"Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bio-Techne (NASDAQ:TECH) and the best and worst performers in the research tools & consumables industry."
04-06-2025,Tracking Dan Loeb's Third Point Portfolio - Q1 2025 Update,SeekingAlpha,"Explore Third Pointâs Q1 2025 portfolio shifts, new investments, stake increases, and high-conviction strategies for long-term market outperformance."
05-06-2025,3 Reasons to Avoid DHR and 1 Stock to Buy Instead,Yahoo,"Over the past six months, Danaher’s shares (currently trading at $193.08) have posted a disappointing 15.3% loss while the S&P 500 was down 1.8%. This may have investors wondering how to approach the situation."
07-06-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
10-06-2025,Danaher : Sustainability report (Danaher 2025 Sustainability Report),Finnhub,ility Innovation at the speed of life danaher All of the photographs featured throughout this report were taken...
10-06-2025,Danaher Corp. stock underperforms Monday when compared to competitors despite daily gains,MarketWatch,Danaher Corp. stock underperforms Monday when compared to competitors despite daily gains
11-06-2025,CVS vs. DHR: Which Stock Should Value Investors Buy Now?,Yahoo,CVS vs. DHR: Which Stock Is the Better Value Option?
11-06-2025,Tesla Stock Has Lost Its Trump Bump. How to Play the Shares Now.,MarketWatch,Tesla Stock Has Lost Its Trump Bump. How to Play the Shares Now.
11-06-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
12-06-2025,3 of Wall Street’s Favorite Stocks Skating on Thin Ice,Yahoo,"Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover."
14-06-2025,"Top Analyst Reports for Eli Lilly, Home Depot & SAP",Yahoo,"Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company, The Home Depot and SAP SE."
14-06-2025,Danaher Corp. stock outperforms competitors despite losses on the day,MarketWatch,Danaher Corp. stock outperforms competitors despite losses on the day
17-06-2025,Q1 Earnings Highlights: Agilent (NYSE:A) Vs The Rest Of The Research Tools & Consumables Stocks,Yahoo,"As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the research tools & consumables industry, including Agilent (NYSE:A) and its peers."
18-06-2025,Danaher Schedules Second Quarter 2025 Earnings Conference Call,Yahoo,"Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the second quarter 2025 on Tuesday, July 22, 2025 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations."
18-06-2025,Danaher Corp. stock outperforms competitors despite losses on the day,MarketWatch,Danaher Corp. stock outperforms competitors despite losses on the day
19-06-2025,Danaher: High Capex And Low Debt Despite Trump Legislation,SeekingAlpha,
20-06-2025,Why Danaher (DHR) is a Top Growth Stock for the Long-Term,Yahoo,"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores."
21-06-2025,"Dividend Champion, Contender, And Challenger Highlights: Week Of June 22",SeekingAlpha,
21-06-2025,Danaher Corp. stock underperforms Friday when compared to competitors despite daily gains,MarketWatch,Danaher Corp. stock underperforms Friday when compared to competitors despite daily gains
22-06-2025,"GE Healthcare: Near-Term Margin Headwinds Priced In, Long-Term Growth Driven By New Products And M&As",SeekingAlpha,"Discover why GE Healthcare is set for growth with strong innovation, backlog, and China's demand. Read more here."
24-06-2025,Danaher Corporation (DHR): A Bull Case Theory,Yahoo,"We came across a bullish thesis on Danaher Corporation (DHR) on FluentInQuality’s Substack. In this article, we will summarize the bulls’ thesis on DHR. Danaher Corporation (DHR)’s share was trading at $202.62 as of 10th June. DHR’s trailing and forward P/E were 38.6 and 26.39 respectively according to Yahoo Finance. Danaher is a masterclass in disciplined compounding, […]"
25-06-2025,Oligonucleotide Synthesis Market Research and Global Forecast Report 2025-2030: Rising Emphasis on Advancing Drug Delivery and Scalable Synthesis Technologies for Oligonucleotide-Based Therapeutics,Yahoo,"The oligonucleotide synthesis market is forecasted to grow from USD 10.5 billion in 2025 to USD 24.7 billion by 2030 (CAGR of 18.6%). Key drivers include increasing demand for synthesized oligonucleotides for research and diagnostics, along with advancements in synthesis technology. By 2024, the oligonucleotide-based drugs segment is expected to dominate, driven by rising acceptance for treating rare diseases. North America leads the market due to established healthcare infrastructure and strong"
25-06-2025,"Fortive Corporation (FTV) Is A “Great” Company, Says Jim Cramer",Yahoo,"Fortive Corporation (NYSE:FTV) is one of the Jim Cramer Discusses US-China Trade War & These 10 Stocks. Fortive Corporation (NYSE:FTV) is also an industrial products company. The firm sells testing, compliance, and measurement equipment to the industrial, automotive, healthcare, and other industries. Fortive Corporation (NYSE:FTV)’s shares have lost 6.4% year-to-date, primarily on the back of […]"
26-06-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
26-06-2025,"Opus Water Launches -- Serving the Water, Wastewater and Industrial Process Fluids Industries",Yahoo,"Opus Water is a newly formed engineered products water company providing innovative, reliable solutions that deliver water safely and efficiently in some of the world's most demanding applications. Backed by XPV Water Partners, Opus Water enters the market with a suite of offerings including pipe plugs, strainers, and heat exchangers. Opus Water serves customers across municipal, industrial, and specialty markets where performance, durability, and responsiveness are critical."
26-06-2025,"Danaher Corporation (DHR) Is “Fool’s Gold,” Bemoans Jim Cramer",Yahoo,Danaher Corporation (NYSE:DHR) is one of the Jim Cramer Discusses US-China Trade War & These 10 Stocks. Danaher Corporation (NYSE:DHR) is one of the largest industrial and medical research products manufacturers in America. It has been one of the most troubled stocks this year as the shares have lost 14.5% year-to-date. Danaher Corporation (NYSE:DHR)’s shares […]
27-06-2025,CVS vs. DHR: Which Stock Is the Better Value Option?,Yahoo,CVS vs. DHR: Which Stock Is the Better Value Option?
27-06-2025,"Danaher Corporation Appoints Martin Stumpe as Chief Technology and AI Officer, Effective October 1, 2025",Finnhub,"Danaher Corporation announced that Martin Stumpe will be appointed Chief Technology and AI Officer, effective October 1, 2025. This appointment marks a pivotal step in Danaher's digital transformation..."
27-06-2025,Danaher Appoints Martin Stumpe as Chief Technology and AI Officer,Yahoo,"Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Martin Stumpe will be appointed Chief Technology and AI Officer, effective October 1, 2025. He will report directly to Rainer Blair, President and Chief Executive Officer."
27-06-2025,"Danaher appoints Greg Milosevich to Executive Vice President, Life Sciences",Yahoo,"Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Greg Milosevich has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Life Sciences business, effective July 1, 2025."
27-06-2025,"Danaher Corporation Appoints Greg Milosevich to Executive Vice President, Life Sciences Business, Effective July 1, 2025",Finnhub,"Danaher Corporation announced that Greg Milosevich has been appointed by its Board of Directors to be Executive Vice President of Danaher with responsibility for its Life Sciences business, effective..."
27-06-2025,1 Industrials Stock for Long-Term Investors and 2 to Ignore,Yahoo,"Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But this role also comes with a demand profile tethered to the ebbs and flows of the broader economy. Thankfully, industrial end markets were stable over the past six months as the industry’s 1.5% gain has nearly mirrored the S&P 500."
28-06-2025,Danaher Corp. stock underperforms Friday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Friday when compared to competitors
29-06-2025,Is Danaher's M&A Premium Already Priced In?,Yahoo,Growing at a decent rate and available at reasonable valuations.
29-06-2025,Jim Cramer on Danaher: “This Stock Has Been Such a Disappointment for Me”,Yahoo,"Danaher Corporation (NYSE:DHR) is one of the 11 stocks Jim Cramer put under the microscope recently. Highlighting the company’s history of good acquisitions and strength during uncertain times, a caller asked about the company. In response, Cramer said: “I am horrified about what’s happening at Danaher. Everything you said is true, but the CEO, Rainer […]"
30-06-2025,Danaher appoints Martin Stumpe as chief technology and AI officer,Yahoo,The company said Stumpe’s promotion is a “pivotal step in [its] digital transformation and its ambition to lead the next era of innovation in life sciences and diagnostics.”
30-06-2025,"Danaher: Biotech Momentum, Cost Cuts And Valuation Re-Rating Should Drive Upside",SeekingAlpha,"Danaher is positioned for a revenue rebound, led by strong bioprocessing demand and resilient recurring sales. Read why DHR stock is a Buy."
01-07-2025,Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio,Yahoo,"Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores."
02-07-2025,Jim Cramer on Thermo Fisher: “It Does Seem Like it’s Bottoming”,Yahoo,"Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the 21 stocks on Jim Cramer’s radar. Expressing that they believe that the stock has significant potential for growth, a caller inquired about TMO. In response, Cramer said: “This stock is unbelievable. It was a, it’s a great company. Marc Casper does a terrific job, but we […]"
02-07-2025,Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains,MarketWatch,Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains
03-07-2025,"Biopharmaceuticals Manufacturing Consumables Testing Market 2025-2030: Thermo Fisher Scientific, Danaher Corporation, and Merck Lead",Yahoo,"Demand for validated consumables and innovative testing methods like PCR and chromatography persists, driven by regulatory needs and environmental considerations Biopharmaceuticals Manufacturing Consumables Testing Market Biopharmaceuticals Manufacturing Consumables Testing Market Dublin, July 03, 2025 (GLOBE NEWSWIRE) -- The ""Biopharmaceuticals Manufacturing Consumables Testing Market by Product Type, Testing Type, Technology, Application, End User - Global Forecast to 2030"" has been added to R"
05-07-2025,Jim Cramer Says “Danaher Can Make a Comeback”,Yahoo,"Danaher Corporation (NYSE:DHR) is one of the 22 stocks Jim Cramer recently talked about. A caller inquired if Cramer thinks it is time to get back into the stock, and here’s what Mad Money’s host had to say in response: “Okay, well, let me tell you, we never left it for the Charitable Trust because […]"
06-07-2025,Spectris: Takeover Highlights Hidden Value In U.K. Small-Cap Stocks,SeekingAlpha,"Spectris' takeover offers highlight how deeply undervalued UK small- and mid-cap stocks are, especially versus US peers. Read why SEPJF stock is a Hold."
08-07-2025,Johnson Controls: Portfolio Transformation And Megatrends Support Re-Rating,SeekingAlpha,"Johnson Controls trades at a premium vs. historical avg., but valuation is justified by exposure to secular growth trends and a stronger, recurring revenue mix. Learn more on JCI stock here."
08-07-2025,"Liquid Handling Systems Market Insights Report 2025-2030 | Advancements in Microplate Reagent Dispensers, Transformation in Genomics, Importance in Drug Discovery & Development, Lab Automation",Yahoo,"The Liquid Handling Systems Market is anticipated to grow from USD 4.34 billion in 2024 to USD 6.75 billion by 2030, with a CAGR of 7.64%. Key drivers include the increased focus on lab automation and its role in drug discovery. The pipettes segment leads by product share in 2024, while the manual method segment shows the highest growth. The pharma and biotech sector is the primary end-user, and North America holds the largest regional market share. Major players include Agilent Technologies, Da"
08-07-2025,Danaher Corp. stock outperforms competitors despite losses on the day,MarketWatch,Danaher Corp. stock outperforms competitors despite losses on the day
10-07-2025,ClearBridge Sustainability Leaders Strategy Q2 2025 Commentary,SeekingAlpha,The ClearBridge Sustainability Leaders Strategy outperformed its Russell 3000 Index benchmark in the second quarter. Read more here.
11-07-2025,"CoreWeave initiated, Texas Instruments upgraded: Wall Street's top analyst calls",Yahoo,"CoreWeave initiated, Texas Instruments upgraded: Wall Street's top analyst calls"
11-07-2025,Danaher Corp. stock underperforms Thursday when compared to competitors despite daily gains,MarketWatch,Danaher Corp. stock underperforms Thursday when compared to competitors despite daily gains
13-07-2025,Danaher (DHR) Teams Up to Advance Precision Medicine Diagnostics,Yahoo,"Danaher Corporation (NYSE:DHR) is one of the 13 Best Large Cap Stocks to Buy Right Now. On May 29, Danaher Corporation (NYSE:DHR) announced a new partnership with AstraZeneca to scale precision medicine. This partnership aims to create and commercialize novel diagnostic tools and tests, including the new generation of AI-powered diagnostics. These tools and tests […]"
15-07-2025,Harding Loevner Global Equity Q2 2025 Report,SeekingAlpha,"The Global Equity composite rose 10.3% gross of fees in the second quarter, lagging the 11.7% gain in the MSCI ACWI Index."
15-07-2025,Parnassus Value Equity Fund Q2 2025 Commentary,SeekingAlpha,
15-07-2025,Parnassus Core Equity Fund Q2 2025 Commentary,SeekingAlpha,
15-07-2025,Parnassus Core Select ETF Q2 2025 Commentary,SeekingAlpha,
15-07-2025,Danaher Corp. stock underperforms Monday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Monday when compared to competitors
16-07-2025,"Saudi Arabia In-Vitro Diagnostics Market Report 2025-2030 Featuring Abbott, BD, Bio-Rad Laboratories, Biomerieux, Danaher, Nihon Kohden, Roche, Siemens Healthineers, Sysmex, Thermo Fischer Scientific",Yahoo,"Saudi Arabia's in-vitro diagnostics market is set to grow from USD 734.7M in 2024 to USD 932.3M by 2030, driven by a rising elderly population and chronic disease prevalence. Saudi Arabia leads the GCC region in IVD, benefiting from government initiatives like Vision 2030 and healthcare sector advances.Dublin, July 16, 2025 (GLOBE NEWSWIRE) -- The ""Saudi Arabia In-Vitro Diagnostics (IVD) Market (By Segment, Application, Product, End User), Size, Share, Major Deals, Key Company Profiles, Revenue,"
16-07-2025,Danaher Corp. stock underperforms Tuesday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Tuesday when compared to competitors
17-07-2025,Danaher (DHR) Q2 Earnings on the Horizon: Analysts' Insights on Key Performance Measures,Yahoo,"Evaluate the expected performance of Danaher (DHR) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight."
17-07-2025,45 Barron's 2025 Mid-Year Pro-Picks: 3 Ideal July DiviDogs,SeekingAlpha,
18-07-2025,Danaher Gears Up to Post Q2 Earnings: What Lies Ahead for the Stock?,Yahoo,"DHR's Q2 results are likely to reflect Life Sciences weakness, but strength in Biotechnology & Diagnostics units and Abcam acquisition add upside potential."
18-07-2025,"Medical Filtration Company Benchmark Report 2025 | Merck KGaA, 3M, and Danaher Strengthen Medical Filtration Market Leadership Through Strategic Expansions, Spin-Offs, and Mergers",Yahoo,"The Medical Filtration Companies Quadrant offers a detailed analysis of the global medical filtration market, spotlighting key players, technological advancements, and market trends. This report categorizes the top 15 companies, including leaders like Merck KGaA, 3M, and Danaher, each excelling in areas such as healthcare and life sciences. Medical filtration is crucial for removing contaminants from fluids, ensuring safety and purity in applications like dialysis and drug delivery. Techniques i"
19-07-2025,‘Too Cheap to Ignore’: Scotiabank Says There’s an Opportunity Brewing in These 2 Large Cap Healthcare Stocks,Yahoo,"President Donald Trump’s new second term is young, but some of its patterns are already clear. The President has no interest in keeping the government’s sacred cows intact, and large swaths of Federal spending are on the chopping block. Healthcare funding, long a third rail in politics, is among those endangered sectors. The Trump Administration has already cut back on funding for various academic research institutions and government agencies. Uncertainty around trade and tariff policy, and the"
19-07-2025,"Alphabet and Tesla Earnings, Powell Speech and More: What to Watch Next Week",Yahoo,"Earnings season rolls on next week with the first of the Magnificent Seven tech names to report, Tesla and Alphabet. New economic data will shed more light on how tariffs are affecting U.S. consumer and business spending."
19-07-2025,"Dividend Champion, Contender, And Challenger Highlights: Week Of July 20",SeekingAlpha,"Stay informed with this week's dividend updates for Dividend Champions, Contenders, and Challengers. Read the latest updates here."
19-07-2025,Danaher Corp. stock underperforms Friday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Friday when compared to competitors
21-07-2025,"India In Vitro Diagnostics (IVD) Industry Analysis & Forecast (2025-2034) Featuring Roche, Transasia Bio-Medicals, Bio-Rad Labs, BioMerieux, Sysmex, Abbott, Thermo Fisher Scientific, QIAGEN, Quidel, Danaher",Yahoo,"The market's 6.10% CAGR reflects advances in molecular diagnostics, healthcare infrastructure expansion, and personalized medicine. Key trends include companies like Sysmex enhancing local operations and WHO expanding diabetes-related IVDs. Abbott, Qiagen, Quidel, and Danaher lead the market's innovation-driven growth.Dublin, July 21, 2025 (GLOBE NEWSWIRE) -- The ""India In Vitro Diagnostics Market Report and Forecast 2025-2034"" has been added to ResearchAndMarkets.com's offering. The India in vi"
21-07-2025,"Alphabet and Tesla Earnings, Powell Speech and More: What to Watch This Week",Yahoo,"Earnings season rolls on this week with the first of the Magnificent Seven tech names to report, Tesla and Alphabet. New economic data will shed more light on how tariffs are affecting consumer and business spending, and Federal Reserve Chair Jerome Powell is slated to speak on bank regulation."
21-07-2025,Danaher (DHR) Reports Q2: Everything You Need To Know Ahead Of Earnings,Yahoo,Diversified science and technology company Danaher (NYSE:DHR) will be reporting earnings this Tuesday before market hours. Here’s what to look for.
21-07-2025,Donald Trump faces frosty reception on Aberdeen golf trip,Yahoo,Hello and welcome to the working week.I must start with a thank you to my colleague Harvey for stepping in for me last week while I took an early...
22-07-2025,"Danaher Q2 Earnings Beat Estimates, Life Sciences Sales Up Y/Y",Yahoo,"DHR tops Q2 estimates with strong sales across segments, lifting its 2025 EPS outlook amid mixed margin trends."
22-07-2025,"Stocks to Watch Tuesday: RTX, Lockheed Martin, Coca-Cola, GM",Yahoo,"? Coca-Cola (KO): The soda maker reported mixed quarterly results, but nudged up its annual earnings outlook. The company confirmed it will roll out a cane-sugar Coke option. ↘️ RTX (RTX): Results from the aerospace and defense company beat projections, but it sliced its earnings outlook, as tariffs sting."
22-07-2025,"Stocks to Watch Tuesday: Coca-Cola, GM, RTX",Yahoo,"? Coca-Cola (KO): The beverage maker reported mixed quarterly results, but nudged up its annual adjusted earnings outlook. Shares fell more than 1%. ↘️ RTX (RTX): Quarterly results from the aerospace and defense company beat projections, but it sliced its outlook for adjusted earnings per share, as tariffs sting."
22-07-2025,Danaher (DHR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates,Yahoo,"The headline numbers for Danaher (DHR) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals."
22-07-2025,Danaher Corporation (DHR) Q2 2025 Earnings Call Transcript,SeekingAlpha,
22-07-2025,"Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday as More Corporate Earnings Awaited",Yahoo,The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.2% and the actively tr
22-07-2025,"Stocks Down Pre-Bell Ahead of Key Earnings, Fed Chair Powell's Speech",Yahoo,US equity futures were trending downwards on Tuesday as traders await the latest batch of corporate
22-07-2025,Danaher (DHR) Q2 Earnings and Revenues Top Estimates,Yahoo,"Danaher (DHR) delivered earnings and revenue surprises of +9.76% and +1.71%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?"
22-07-2025,"Danaher shares slip despite Q2 beat, annual profit outlook hike",Yahoo,"Investing.com -- Danaher (NYSE:DHR) delivered stronger-than-expected second-quarter results and lifted its full-year profit outlook. Still, the company’s shares fell over 2% in premarket trading on Tuesday."
22-07-2025,Deep Sail Capital Partner Q2 2025 Investor Letter,SeekingAlpha,
22-07-2025,Danaher: Q2 Earnings Snapshot,Yahoo,"The results beat Wall Street expectations. The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $1.64 per share. The industrial and medical device maker posted revenue of $5.94 billion in the period, which also topped Street forecasts."
22-07-2025,Danaher’s (NYSE:DHR) Q2 Sales Top Estimates But Quarterly Revenue Guidance Slightly Misses Expectations,Yahoo,"Diversified science and technology company Danaher (NYSE:DHR) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 3.4% year on year to $5.94 billion. On the other hand, next quarter’s revenue guidance of $5.94 billion was less impressive, coming in 1% below analysts’ estimates. Its non-GAAP profit of $1.80 per share was 9.5% above analysts’ consensus estimates."
22-07-2025,Danaher Announces Transition Plan for Chief Financial Officer,Yahoo,"Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Matthew Gugino, currently Group Chief Financial Officer of the Company's Life Sciences Innovations Group and Vice President of Financial Planning & Analysis, will succeed Matthew McGrew as Danaher's Chief Financial Officer effective February 28th, 2026. Following the transition and consistent with past practice, Mr. McGrew will continue thereafter as an Executive Vice President of the"
22-07-2025,Danaher Reports Second Quarter 2025 Results,Yahoo,"Danaher Corporation (NYSE: DHR) (the ""Company"") today announced results for the quarter ended June 27, 2025."
22-07-2025,"Alphabet and Tesla Earnings, Home Sales and More: What to Watch This Week",Yahoo,"Earnings season rolls on this week, with the first of the Magnificent Seven tech names to report, Tesla and Google parent Alphabet. New economic data will shed more light on how tariffs are affecting consumer and business spending, and Federal Reserve Chair Jerome Powell is slated to speak on bank regulation."
22-07-2025,Danaher Corp. stock outperforms competitors despite losses on the day,MarketWatch,Danaher Corp. stock outperforms competitors despite losses on the day
23-07-2025,Here's Why Danaher (DHR) is a Strong Growth Stock,Yahoo,The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
23-07-2025,Thermo Fisher beats quarterly estimates on resilient demand for its tools and services,Yahoo,"Shares of the medical equipment maker were up 2.5% in premarket trading.  The company joins peers such as Danaher in beating quarterly profit estimates, citing strong demand from the industry for tools and services used to make vaccines and therapies.  Danaher said on Tuesday it is seeing a robust number of clinical trials and therapies under development, with steady demand from its pharmaceutical clients."
23-07-2025,Danaher Stock: Attractively Valued And Poised For Growth Acceleration,SeekingAlpha,"Danaher Corporation thrives on bioprocessing demand & diagnostics resilience. Click for why, with solid execution & 80% recurring revenue, DHR offers upside."
23-07-2025,Baron Health Care Fund Q2 2025 Shareholder Letter,SeekingAlpha,
23-07-2025,Danaher Corp (DHR) Q2 2025 Earnings Call Highlights: Strong Cash Flow and Bioprocessing Growth ...,Yahoo,"Danaher Corp (DHR) reports robust free cash flow and bioprocessing growth, while navigating global trade tensions and Life Sciences segment challenges."
23-07-2025,"Danaher Lifts 2025 Earnings Outlook Amid Biotech Growth, Cost Discipline",Yahoo,"Danaher Corp (NYSE:DHR) on Tuesday reported second-quarter 2025 sales of $5.94 billion, up 3.5% year-over-year, beating the consensus of $5.84 billion. The life science giant reported adjusted earnings of $1.80 per share, beating the consensus of $1.64. Non-GAAP core revenue increased 1.5% year over year, compared to the expectations of a growth in low single digits year over year. Operating cash flow was $1.3 billion, and non-GAAP free cash flow was $1.1 billion. Danaher's second-quarter adjust"
23-07-2025,Steven Cohen's Strategic Moves: A Closer Look at Danaher Corp's Impact on His Portfolio,Yahoo,"Insights from Steven Cohen (Trades, Portfolio)'s First Quarter 2025 13F Filing"
24-07-2025,CVS or DHR: Which Is the Better Value Stock Right Now?,Yahoo,CVS vs. DHR: Which Stock Is the Better Value Option?
24-07-2025,Danaher Q2 2025 Update,SeekingAlpha,"While S&P 500 is at its all-time high, Danaher is still ~34% below its peak from late 2021. Click to read."
24-07-2025,Akre Focus Fund Q2 2025 Commentary,SeekingAlpha,Akre Focus Fund Q2 update highlights quality-driven compounding over bounce-driven gains. Learn why patience and selectivity pay off long term.
24-07-2025,Danaher Corp. stock underperforms Wednesday when compared to competitors despite daily gains,MarketWatch,Danaher Corp. stock underperforms Wednesday when compared to competitors despite daily gains
25-07-2025,Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick,Yahoo,"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service."
25-07-2025,1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down,Yahoo,"The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some are struggling with slowing growth, declining margins, or increased competition."
25-07-2025,NZS Capital Q2 2025 Shareholder Letter,SeekingAlpha,NZS Capital reports a 19.39% Q2 gain for its Growth Equity strategy. See how resilient tech picks and smart reallocation drove results. Review the playbook.
25-07-2025,"Contract research firms' strong earnings signal stabilizing biotech, pharma spending",Yahoo,"(Reuters) -Contract research organizations are reporting better-than-expected second-quarter profit, a sign that Wall Street analysts say reflects a rebound in biotech and pharmaceutical spending after a cautious stretch driven by tighter sector financing.  Danaher, Medpace, IQVIA, ICON and Thermo Fisher have posted strong results owing to steady demand from the industry for tools and services that are used in the development of novel medicines.  ""Biotech funding has started to tick up month over month from April to June, and perhaps our biggest takeaway from IQVIA results as well as Medpace is that the macro environment, while still challenged, has perhaps stabilized,"" said TD Cowen analyst Charles Rhyee."
26-07-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
27-07-2025,"Danaher Corporation (DHR)’s Been A Disaster, Says Jim Cramer",Yahoo,"We recently published 10 Stocks Jim Cramer Talked About As He Said Everyone Won From Trump’s Japan Deal. Danaher Corporation (NYSE:DHR) is one of the stocks Jim Cramer recently discussed. Danaher Corporation (NYSE:DHR) is an American life sciences, diagnostics, and biotechnology equipment provider. Its shares have lost 11% year-to-date, and Cramer isn’t a fan of […]"
27-07-2025,"MCN: The Yield Is Nice, But This Fund Is Hard To Recommend",SeekingAlpha,"Discover insights on the XAI Madison Equity Premium Income Fund's 11.5% yield, NAV performance, and sustainability challenges."
27-07-2025,Built To Last: My 16-Stock Dividend Pyramid Portfolio,SeekingAlpha,"Discover how restructuring a dividend portfolio into Albanian real estate and applying the pyramid method enhances diversification, risk balance, and the future."
28-07-2025,"Revvity Q2: Headwinds From China And Customers, Buy On Weakness",SeekingAlpha,"Revvity, Inc. targets high-growth markets like cell and gene therapies and precision medicine. Click for more on RVTY stock and why I'm bullish."
28-07-2025,International Markets and Danaher (DHR): A Deep Dive for Investors,Yahoo,Explore how Danaher's (DHR) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
29-07-2025,Where this large cap portfolio manager see opportunity now,Yahoo,"Looking for a large-cap stock to invest in? In the video above, Macquarie Large Cap Growth Team senior portfolio manager Brad Klapmeyer shares some of the sectors and stocks he's taking a closer look at. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here."
29-07-2025,5 Revealing Analyst Questions From Danaher’s Q2 Earnings Call,Yahoo,"Danaher’s second quarter results came in ahead of Wall Street’s revenue and profit expectations, with steady growth in its bioprocessing business and disciplined cost management highlighted by management as key contributors. CEO Rainer Blair pointed to “strong growth in our bioprocessing business, paired with disciplined cost management,” as drivers behind the quarter’s performance. Despite ongoing global trade tensions and a soft environment for academic and government research, the company saw"
29-07-2025,Veralto lifts annual profit forecast on water treatment demand,Yahoo,"Veralto raised its full-year profit forecast and beat quarterly estimates on Monday, helped by strong demand for its industrial water treatment services. Shares of the company rose 1.4% in extended trade. The Waltham, Massachusetts-based company provides water treatment solutions to industrial customers that help ensure quality, alongside packaging and quality control services."
29-07-2025,Danaher Corp. stock underperforms Monday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Monday when compared to competitors
30-07-2025,"Aldevron Launches New Innovation Center in Waltham, MA",Yahoo,"FARGO, N.D. & WALTHAM, Mass., July 30, 2025--Aldevron is expanding into Waltham, MA, a strategic move to help grow its innovation capabilities in gene editing and mRNA."
30-07-2025,"Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic",Yahoo,"The global Drug Abuse Testing Market is set to surge, reaching $12.77 billion by 2033 from $6.64 billion in 2024, experiencing a CAGR of 7.54% between 2025-2033. This growth is driven by rising drug abuse rates, enhanced public awareness, and strict laws. Technological advancements in testing and an increased emphasis on preventative healthcare further boost the market. Key product and service segments include analyzers, rapid testing devices, and laboratory services, with urine tests dominating"
30-07-2025,Got $500? 3 Blue Chip Dividend Stocks to Buy and Hold Forever,Yahoo,Being a great investor doesn't have to be complicated or expensive.
30-07-2025,Jim Cramer on Danaher: “I Think We’ve Finally Reached the Tipping Point”,Yahoo,"Danaher Corporation (NYSE:DHR) is one of the stocks Jim Cramer shed light on. While discussing the stock’s condition over the past couple of years, Cramer showed a positive sentiment toward the stock, as he said: “Now, we bought this one in early 2022… I expected the business to stabilize and the stock to make a […]"
30-07-2025,"Danaher Corporation (DHR): Maybe It Can Be Great Again, Says Jim Cramer",Yahoo,We recently published 11 Stocks That Jim Cramer Recently Talked About. Danaher Corporation (NYSE:DHR) is one of the stocks Jim Cramer recently discussed. Danaher Corporation (NYSE:DHR) is a stock that Jim Cramer has a bittersweet relationship with. His trust has continued to hold the shares despite the fact that they have lost 11.7% year-to-date. The […]
30-07-2025,"Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report",Yahoo,"A new report from Kalorama Information reveals that the global point-of-care (POC) diagnostics market surged past $36 billion in 2024, with projections pointing to continued growth through 2029. The twelfth edition of Worldwide Market for Point-of-Care Diagnostic Tests, 12th Edition highlights how decentralization of healthcare, rapid innovation, and consumer-driven demand are reshaping how and where diagnostic tests are performed—from traditional clinical settings to homes, workplaces, and remo"
30-07-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
31-07-2025,Danaher Corp. stock underperforms Wednesday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Wednesday when compared to competitors
01-08-2025,Danaher Appoints Jonathan Leiken as General Counsel,Yahoo,"Danaher Corporation (NYSE: DHR), a leading global life sciences and diagnostics innovator, today announced that Jonathan Leiken has been appointed Senior Vice President and General Counsel, effective August 25, 2025. Mr. Leiken will report directly to President and Chief Executive Officer Rainer Blair and will serve as an executive officer and a member of the Danaher Leadership Team."
01-08-2025,Danaher Corp. stock underperforms Thursday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Thursday when compared to competitors
02-08-2025,Buy Graham Holdings Stock. Its Parts Are Worth More Than the Whole.,Yahoo,"Graham owns an array of businesses including Kaplan test prep, and has family ties to Berkshire Hathaway. The stock looks cheap."
02-08-2025,"Markel's Q2 Earnings Surpass Estimates, Premiums Rise Y/Y",Yahoo,"MKL tops Q2 earnings and revenue estimates, but profits dip as rising expenses weigh on margins."
04-08-2025,Janus Henderson Concentrated Growth Managed Account Q2 2025 Commentary,SeekingAlpha,Janus Henderson Concentrated Growth Managed Account returned 18.47% (gross) and the Russell 1000Â® Growth Index returned 17.84%. Read more here.
04-08-2025,Janus Henderson Concentrated All Cap Growth Managed Account Q2 2025 Commentary,SeekingAlpha,Concentrated All Cap Growth Managed Account returned 20.12% (gross) and the Russell 3000Â® Growth Index returned 17.55%. Read more here.
05-08-2025,Danaher Insiders Sold US$250m Of Shares Suggesting Hesitancy,Yahoo,The fact that multiple Danaher Corporation ( NYSE:DHR ) insiders offloaded a considerable amount of shares over the...
05-08-2025,Bio-Techne: Coveted Life Sciences Asset On Sale Due To Academic Pressures,SeekingAlpha,Headwaters Capital sees deep value in Bio-Techne as academic cuts weigh on shares. Learn why this life sciences leader could rebound in 2027âread the thesis.
05-08-2025,Janus Henderson Forty Fund Q2 2025 Commentary,SeekingAlpha,Janus Henderson Forty Fund returned 19.34% and the Russell 1000Â® Growth Index returned 17.84%. Read more here.
06-08-2025,Bio-Techne beats quarterly estimates on strength in protein sciences unit,Yahoo,"Bio-Techne reported better-than-expected fourth-quarter revenue and profit on Wednesday, helped by steady demand for its proteins, antibodies and other products for research. The Minneapolis, Minnesota-based company develops and makes products used in medical research, drug development and diagnostics. Larger peers Thermo Fisher and Danaher last month flagged robust demand across regions for their drug development products such as instruments and analytical tools after two years of weak biotech funding."
06-08-2025,Charles River raises profit forecast on growing demand for drug development services,Yahoo,"The Wilmington, Massachusetts-based contract drug developer raised its 2025 adjusted profit forecast to $9.90 to $10.30 per share, compared with its previous projection of $9.30 to $9.80.  Contract research organizations, which reported quarterly results over the last month, have all posted better-than-expected profit, reflecting a rebound in spending from pharmaceutical and biotech clients after a cautious stretch driven by tighter sector financing.  ""We are continuing to see clear signs that the biopharmaceutical demand is stabilizing, and in this environment, we are making gradual progress to return to organic revenue growth,"" Charles River CEO James Foster said."
07-08-2025,Why This 1 Value Stock Could Be a Great Addition to Your Portfolio,Yahoo,"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service."
07-08-2025,Danaher Corp. stock outperforms competitors despite losses on the day,MarketWatch,Danaher Corp. stock outperforms competitors despite losses on the day
08-08-2025,Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?,Yahoo,"HOLX's Diagnostics arm eyes long-term growth with new assays, platform expansion and oncology test adoption despite headwinds."
08-08-2025,"Agilent: A Lean, Focused Play In Life Sciences Tools Amid Tariff Turbulence",SeekingAlpha,"Agilent remains a strong life science leader with solid financials and strategic resilience, but near-term headwinds temper upside. See why A stock is a hold."
08-08-2025,Precipio: Cash Flow Positivity May Remove Going Concern Language,SeekingAlpha,Deep Sail Capital highlights Precipioâs path to cash flow positivity and niche growth in cancer diagnostics. See why its turnaround story deserves a closer look.
08-08-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
09-08-2025,Danaher Corp. stock underperforms Friday when compared to competitors despite daily gains,MarketWatch,Danaher Corp. stock underperforms Friday when compared to competitors despite daily gains
11-08-2025,CVS or DHR: Which Is the Better Value Stock Right Now?,Yahoo,CVS vs. DHR: Which Stock Is the Better Value Option?
12-08-2025,Genedata Next-Gen Software to Power GMP-Compliant NGS in Biopharma Manufacturing,Yahoo,"Genedata, a Danaher company, and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced a new release of Genedata Selector®. This end-to-end solution automates next-generation sequencing (NGS) data processing and analysis, accelerating decision-making for more efficient quality control of advanced therapies. The new version of Genedata Selector further enhances data integrity by seamlessly connecting systems, facilitating efficient transfer of data, proj"
12-08-2025,"STD Diagnostic Market Forecast and Company Analysis Report 2025-2033 Featuring Siemens, Abbott, MedMira, QIAGEN, Danaher, F. Hoffmann-La Roche, Diasorin, BioMeriuex, Hologic, Bio-Rad Laboratories",Yahoo,"The STD Diagnostic Market is projected to reach $17.93 billion by 2033, growing from $9.82 billion in 2024 at a CAGR of 6.92% during 2025-2033. Key growth drivers include increased STD prevalence, technological advancements in diagnostics, and enhanced accessibility to healthcare. Government initiatives and improved public awareness also bolster the market. Segments analyzed include products, testing types, and global regions, emphasizing the demand for point-of-care testing and at-home kits. Si"
13-08-2025,"Saudi Arabia Clinical Chemistry Analyzer Market Forecast and Company Analysis Report 2025-2033 Featuring Thermo Fisher Scientific, Abbott, Siemens, Danaher, J&J, Sysmex ADR, HORIBA, Hitachi",Yahoo,"The Saudi Arabia Clinical Chemistry Analyzer Market is set to reach US$ 249.11 million by 2033, growing from US$ 170.98 million in 2024 at a 4.27% CAGR. Market growth is fueled by government healthcare investments under Vision 2030, alongside rising chronic diseases and an aging population demanding precise diagnostics. Technological advancements in automation, AI integration, and point-of-care testing further enhance accessibility, especially in underserved areas. With increasing involvement fr"
13-08-2025,"Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge",Yahoo,"The Mexico Microcarrier Market is poised for significant growth, projected to reach US$ 77.65 million by 2033 from US$ 39.96 million in 2024, achieving a CAGR of 7.66% from 2025 to 2033. Key drivers include increased investment in regenerative medicine and cell therapy, rising demand for cell-based vaccines and biologics, and technological advancements in cell culture efficiency. Mexico’s biopharmaceutical sector expansion, supported by enhanced bioprocessing infrastructure and strategic public-"
13-08-2025,"[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",Yahoo,"[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of US Personalized Medicine Market size & share revenue was valued at approximately USD 56.37 Billion in 2024 and is expected to reach USD 66.13 Billion in 2025 and is expected to reach around USD 252.93 Billion by 2034, at a CAGR of 17.32% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Illumina Inc., Precision"
13-08-2025,Iftekhar Ahmed: The Global Strategist Quietly Transforming Healthcare Leadership,Yahoo,"With a legacy of global impact, Iftekhar Ahmed brings strategic clarity, cultural fluency, and people-centered leadership to the forefront of healthcare innovation at Danaher. WASHINGTON, DC / ACCESS Newswire / August 12, 2025 / In a rapidly evolving ..."
13-08-2025,Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains,MarketWatch,Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains
14-08-2025,Are Wall Street Analysts Predicting Danaher Stock Will Climb or Sink?,Yahoo,"After weak long-term price action, are analysts bullish or bearish on Danaher Corp stock?"
14-08-2025,BNY Mellon Dynamic Value Fund Q2 2025 Commentary,SeekingAlpha,BNY Mellon Dynamic Value Fund (Class A at NAV) returned 5.00% during the second quarter of 2025. Read more here.
14-08-2025,Is it a Great Time to Invest in Danaher Corp. (DHR)?,Yahoo,"Parnassus Investments, an investment management firm that focuses on owning a concentrated portfolio of U.S. large cap stocks, released its Parnassus Value Equity Fund second-quarter 2025 investor letter. The full letter is available for download here. For the second quarter of 2025, the fund reported a net return of 7.24%, outperforming its benchmark, the Russell 1000 […]"
14-08-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
15-08-2025,2 Profitable Stocks to Consider Right Now and 1 Facing Headwinds,Yahoo,"While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, ""Your margin is my opportunity""."
15-08-2025,"Bruker: Former Academia Customer Strength, Now Incredible Weakness",SeekingAlpha,"Bruker faces challenges amid NIH funding cuts and academic reliance. Short-term risks are high, but investors may benefit from a recovery. See more on BRKR."
17-08-2025,Wells Fargo Reduces PT on Danaher Corporation (DHR) to $205; Maintains ‘Equal Weight’ Rating,Yahoo,"With a year-to-date decline in share price, along with strong hedge fund interest, Danaher Corporation (NYSE:DHR) secures a place on our list of the 11 Best Rebound Stocks to Buy According to Hedge Funds. On July 23, 2025, Wells Fargo reduced its price target on Danaher Corporation (NYSE:DHR) from $210 to $205, maintaining an ‘Equal […]"
17-08-2025,AstroNova: A Textbook Case For Shareholder Activism,SeekingAlpha,"Our AstroNova investment was predicated on the view that this was a low-risk ""under-earner"". So, what went wrong? Click here to find out. "
17-08-2025,Atai Capital Management Q2 2025 Letter,SeekingAlpha,"Atai Capital Management reports a 32.8% Q2 gain, reviews key portfolio moves and lessons from past missteps. Read the full letter for insights and strategy."
18-08-2025,Danaher (DHR) Just Overtook the 200-Day Moving Average,Yahoo,"When a stock breaks out above the 200-day simple moving average, good things could be on the horizon. How should investors react?"
19-08-2025,Macquarie Large Cap Growth Fund Q2 2025 Commentary,SeekingAlpha,"For 2Q25, Macquarie Large Cap Growth Fund Institutional Class shares posted absolute positive returns but underperformed the Fundâs benchmark, the Russell 1000 Growth Index."
19-08-2025,Tracking Al Gore's Generation Investment Management Portfolio - Q2 2025 Update,SeekingAlpha,"Generation IMâs Q2 2025 portfolio value declined to $15.73B, with 37 positions. Click here to read more about the portfolio's new stakes and increases."
20-08-2025,Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains,MarketWatch,Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains
21-08-2025,Danaher (DHR) Up 6.8% Since Last Earnings Report: Can It Continue?,Yahoo,Danaher (DHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
21-08-2025,Qiagen: Diagnostics Vs. Life Sciences Pair Trade Analysis,SeekingAlpha,
22-08-2025,Is Danaher Corporation (DHR) a Quality Compounder With Long-Term Revenue Growth?,Yahoo,Baron Funds released its “Baron Durable Advantage Fund” second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund primarily focuses on investing in securities of large-sized companies. The fund increased 15.6% (Institutional Shares) in the second quarter compared to a 10.9% return for the S&P 500 Index (the Index). The Fund […]
22-08-2025,Danaher Corp. stock underperforms Thursday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Thursday when compared to competitors
25-08-2025,"Hospital Filtration Industry Company Benchmark Report 2025 | Danaher, Veolia, and Pentair Lead by Driving Innovation and Sustainability",Yahoo,"The Hospital Filtration Companies Quadrant provides an in-depth analysis of the global Hospital Filtration market, focusing on key players, innovations, and industry trends. Evaluating over 100 companies, it highlights the Top 13 leaders in hospital filtration, essential in maintaining contaminant-free healthcare environments via HEPA, ULPA, and RO systems. With the growing focus on infection control, this sector is driven by advancements and regulatory norms. Notable companies like Danaher, Veo"
26-08-2025,Modine Manufacturing Company (MOD): A Bull Case Theory,Yahoo,"We came across a bullish thesis on Modine Manufacturing Company on Stock Analysis Compilation’s Substack. In this article, we will summarize the bulls’ thesis on MOD. Modine Manufacturing Company’s share was trading at $138.72 as of August 15th. MOD’s trailing and forward P/E were 39.75 and 31.85, respectively according to Yahoo Finance. Modine Manufacturing is a thermal […]"
26-08-2025,Danaher Corp. stock underperforms Monday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Monday when compared to competitors
26-08-2025,"[Latest] Global Chemical Reagents Market Size/Share Worth USD 26.5 Billion by 2034 at a 7.5 CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)",Yahoo,"[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Chemical Reagents Market size & share revenue was valued at approximately USD 14.1 Billion in 2024 and is expected to reach USD 14.8 Billion in 2025 and is expected to reach around USD 26.5 Billion by 2034, at a CAGR of 7.5 between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are Thermo Fisher Scientific, Merck"
27-08-2025,Tracking Akre Capital Management Portfolio - Q2 2025 Update,SeekingAlpha,"Akre Capital's Q2 2025 portfolio update: see more on shifts in top holdings, new stakes, and their disciplined strategy focusing on high-growth names."
28-08-2025,Why Is Teladoc (TDOC) Up 4.6% Since Last Earnings Report?,Yahoo,Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
28-08-2025,Genedata Advances R&D Efficiency with New Unified Sample Management Solution,Yahoo,"Genedata, a Danaher company and the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the release of a new Sample Management module as part of their Genedata Biopharma Platform. The Genedata Biopharma Platform is the industry's leading platform for discovering and developing novel biotherapeutics, covering the full end-to-end workflow from therapeutics design and engineering to process development. It supports a broad range of therapeutic modalities out"
28-08-2025,mRNA Biotechs - Long-Term Value Risks Abound,SeekingAlpha,mRNA vaccine stocks face challenges post-pandemic. Discover why 'pick-and-shovel' biotech suppliers may offer better investment stability and growth.
02-09-2025,"PFAS Testing Company Evaluation Report 2025 | Agilent, Thermo Fisher, and Danaher Dominate with Advanced Analytical Solutions, Strategic Acquisitions, and Regulatory-Driven Innovations",Yahoo,"The PFAS Testing Companies Quadrant delivers a thorough analysis of the global PFAS Testing market, ranking the top 14 companies from over 100 evaluations. With a spotlight on key players like Agilent Technologies, Thermo Fisher Scientific, and Danaher Corporation, the report explores innovation, technological advancements, and market trends in PFAS detection and analysis. As rising global awareness on environmental contamination boosts market growth, the industry faces challenges like high capi"
02-09-2025,Is Danaher Stock Underperforming the Dow?,Yahoo,"Although Danaher has lagged behind the Dow over the past year, analysts remain bullish about the stock’s prospects."
03-09-2025,Danaher Gains From Business Strength Amid Persisting Headwinds,Yahoo,"DHR posts gains in bioprocessing, biotech and diagnostics, while life sciences softness and high debt weigh."
06-09-2025,A10 Networks Names Michelle Caron as Finance Chief,MarketWatch,A10 Networks Names Michelle Caron as Finance Chief
07-09-2025,Danaher: Not All That Exciting,SeekingAlpha,"Danaher faces revenue pressure and rising leverage despite strong market exposure, making its high valuation harder to justify. Find out why DHR stock is a hold."
08-09-2025,Radioimmunoassay Market Research Report 2025-2033 | Broader Applications Across Developed and Emerging Markets Accelerate Adoption of RIA in Diagnostics and Research,Yahoo,"The global Radioimmunoassay (RIA) market is set to expand from $710 million in 2024 to $1.12 billion by 2033, growing at a CAGR of 5.21%. Key drivers include advancements in endocrinology, oncology, infectious disease research, and wider application of RIA in both advanced and emerging markets. The market is propelled by technological improvements in RIA kits, increased demand for precise disease diagnosis, and growing pharmaceutical applications. However, it faces competition from non-radioacti"
08-09-2025,3 Healthcare Stocks We’re Skeptical Of,Yahoo,"Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag recently - over the past six months, the collective 1.4% gain for healthcare stocks has fallen short of the S&P 500’s 15.5% rise."
09-09-2025,Tracking Dan Loeb's Third Point Portfolio - Q2 2025 Update,SeekingAlpha,"Third Point's Q2 2025 13F portfolio rose to $7.62B, with increased concentration in top holdings. Read more about the portfolio here."
10-09-2025,"Beckman Coulter Diagnostics Launches Industry First Fully Automated, High Throughput BD-Tau Research Use Only Immunoassay Test, Advancing Neurodegenerative Clinical Research",Yahoo,"Beckman Coulter Diagnostics, a Danaher company and a leader in global clinical diagnostics innovation, today launched the industry's first fully automated Brain-derived Tau (BD-Tau) research use only (RUO) immunoassay test. Access BD-Tau, along with Beckman Coulter Diagnostics' expanding portfolio of neurodegenerative disease RUO assays, is available for use on the groundbreaking DxI 9000 Immunoassay Analyzer and Access 2 Analyzer. This portfolio of assays enables precision medicine research on"
10-09-2025,Danaher (DHR) Valuation: Is the Recent Slide an Opportunity for Long-Term Investors?,Yahoo,"If you have been following Danaher (DHR) lately, you may have noticed that the stock’s performance has come under the microscope. While there is no single headline grabbing investor attention, the shares have been trending lower, prompting some to wonder if this slide is a warning sign or simply a possible opening for value-driven buyers. For shareholders, the current environment raises a familiar question: is this move noise, or does it signal something deeper happening at the company? Over..."
10-09-2025,Danaher Announces Quarterly Dividend,Yahoo,"Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on October 31, 2025 to holders of record on September 26, 2025."
10-09-2025,Danaher Corp. stock underperforms Tuesday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Tuesday when compared to competitors
12-09-2025,Danaher's Biotechnology Growth Picks Up: A Sign of More Upside?,Yahoo,"DHR's Biotechnology unit grows 6% in Q2, driven by bioprocessing, despite weakness in research equipment demand."
12-09-2025,Danaher Corp. stock underperforms Thursday when compared to competitors despite daily gains,MarketWatch,Danaher Corp. stock underperforms Thursday when compared to competitors despite daily gains
13-09-2025,Danaher Corp. stock underperforms Friday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Friday when compared to competitors
15-09-2025,Hologic's Breast Health Rebound in Motion: How to Play the Stock Now?,Yahoo,"HOLX's Breast Health revival, fueled by AI, leadership shifts and product upgrades, is setting up a growth rebound."
15-09-2025,Unpacking Q2 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks,Yahoo,The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Danaher (NYSE:DHR) and the rest of the research tools & consumables stocks fared in Q2.
17-09-2025,Danaher's Life Sciences Segment Shrinks: What's the Path Forward?,Yahoo,"DHR's Life Sciences unit faces revenue declines from weak demand, but new products and biotech advances offer growth potential."
18-09-2025,"Danaher Corporation (DHR) Among Most Oversold Stocks, Gains Attention with Strategic Biotech Moves",Yahoo,"In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Danaher Corporation is one of them. Danaher Corporation (NYSE:DHR), a global leader in life sciences and diagnostics, continues to advance its bioprocessing, diagnostics, and life sciences segments through innovation and strategic partnerships. In Q2 2025, […]"
18-09-2025,Consumers Energy Names Shannon Thomas New Chief People Officer,Yahoo,"Consumers Energy today announced Shannon Thomas as the company's senior vice president and chief people officer, effective September 29."
20-09-2025,"Dividend Champion, Contender, And Challenger Highlights: Week Of September 21",SeekingAlpha,"This is our weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the latest in the article series here."
22-09-2025,Can Danaher's Diagnostics Unit Sustain Growth Amid Lower Sales in China?,Yahoo,"DHR's Diagnostics unit posts steady Q2 growth, led by Beckman Coulter demand, while China headwinds weigh on results."
22-09-2025,"Company’s DEI interview quota policy harmed White men, lawsuit alleges",Yahoo,"Danaher Corp. allegedly violated Title VII by artificially populating interview pools with female candidates and people of color to satisfy DEI quotas, according to the complaint."
24-09-2025,1 of Wall Street’s Favorite Stock on Our Watchlist and 2 Facing Headwinds,Yahoo,"The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory."
24-09-2025,Danaher Schedules Third Quarter 2025 Earnings Conference Call,Yahoo,"Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2025 on Tuesday, October 21, 2025 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations."
25-09-2025,Integrated DNA Technologies Launches New Enhancer Protein to Accelerate CRISPR-Based Therapies from Translational Research to Clinical Breakthrough,Yahoo,"CORALVILLE, Iowa, September 25, 2025--New enhancer protein expands IDT's market-leading portfolio of HDR reagents, empowering cell and gene therapy developers to accelerate discoveries"
25-09-2025,Danaher Corp. stock underperforms Wednesday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Wednesday when compared to competitors
26-09-2025,Danaher Corp. stock underperforms Thursday when compared to competitors,MarketWatch,Danaher Corp. stock underperforms Thursday when compared to competitors
27-09-2025,Rosen Law Firm Initiates Investigating Potential Breaches of Fiduciary Duty by Danaher Corporation (DHR),Yahoo,"With significant upside potential, Danaher Corporation (NYSE:DHR) secures a spot on our list of the 13 Best Diversified Stocks to Buy According to Hedge Funds. On September 20, 2025, Rosen Law Firm announced that it is investigating potential breaches of fiduciary duty by Danaher Corporation (NYSE:DHR)’s directors and officers. Accordingly, the law firm encouraged shareholders […]"
27-09-2025,Will Danaher's (DHR) New Gene Editing Tool Redefine Its Position in Advanced Life Sciences?,Yahoo,"Integrated DNA Technologies (IDT), a Danaher company, recently launched the Alt-R HDR Enhancer Protein, designed to improve homology-directed repair efficiency in gene editing and manufactured by Aldevron, which also operates under Danaher. This breakthrough expands Danaher's capabilities in the competitive cell and gene therapy market by providing a solution that increases gene editing efficiency without sacrificing cell viability or genomic integrity. We’ll examine how this new gene..."
27-09-2025,Danaher Corp. stock outperforms competitors on strong trading day,MarketWatch,Danaher Corp. stock outperforms competitors on strong trading day
29-09-2025,Here's Why Envista (NVST) is a Strong Value Stock,Yahoo,"Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service."
30-09-2025,3 Reasons to Sell DHR and 1 Stock to Buy Instead,Yahoo,"Over the last six months, Danaher’s shares have sunk to $186.35, producing a disappointing 9.1% loss - a stark contrast to the S&P 500’s 18.6% gain. This may have investors wondering how to approach the situation."
01-10-2025,Danaher: Balanced Portfolio With Upside Potential In 2026,SeekingAlpha,"Danaher Corporation is undervalued, with strong fundamentals, robust free cash flow, and 12.7% upside. Click here to read why DHR stock is a Buy."
01-10-2025,"Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know",Yahoo,A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry.
01-10-2025,Will A10 Networks’ (ATEN) New CFO Drive Its Next Growth Phase?,Yahoo,"A10 Networks Inc. (NYSE:ATEN) is one of the worst-performing data center stocks in 2025. Its stock is largely flat since the start of the year, which contrasts with the broader strong performance of larger data center-exposed stocks. On September 24, the company’s new CFO, Michelle Caron, took charge from Brian Becker, who has stepped down and […]"
02-10-2025,BLCO vs. DHR: Which Stock Should Value Investors Buy Now?,Yahoo,BLCO vs. DHR: Which Stock Is the Better Value Option?
02-10-2025,Danaher Corporation (DHR) To Release FQ3 Results on October 21,Yahoo,"Danaher Corporation (NYSE:DHR) is one of the Top Blue Chip Stocks to Buy At 52-Week Lows. On September 23, Danaher Corporation (NYSE:DHR) announced that it will release its fiscal third-quarter results on October 21, 2025. The company topped Wall Street estimates during its fiscal second quarter of 2025. It delivered a revenue of $5.94 billion, […]"
02-10-2025,Danaher (DHR) Surges as Pharma Tariffs to Benefit Firm,Yahoo,"We recently published 11 Stocks Crushing Wall Street With Whopping Gains. Danaher Corp. (NYSE:DHR) is one of the top performers on Tuesday. Danaher extended gains to a third consecutive day on Tuesday, jumping 6.56 percent to close at $198.26 apiece and tracking the rally in US pharmaceutical stocks ahead of the imposition of 100 percent […]"
02-10-2025,Why Danaher (DHR) Stock Is Trading Up Today,Yahoo,"Shares of diversified science and technology company Danaher (NYSE:DHR) jumped 6.6% in the afternoon session after its subsidiary, Leica Biosystems, announced the launch of new artificial intelligence (AI)-powered digital pathology solutions."
03-10-2025,BofA Lowers PT on Danaher Corporation (DHR) to $220 From $230,Yahoo,"Danaher Corporation (NYSE:DHR) is one of the best medical stocks to buy now. On September 22, BofA lowered the firm’s price target on Danaher Corporation (NYSE:DHR) to $220 from $230 while keeping a Buy rating on the shares. The firm told investors that although some trends are showing stabilization and/or improvement in certain areas of […]"
03-10-2025,Danaher (DHR): Evaluating Valuation After AI Pathology Launch and Pharma Sector Boost,Yahoo,"Danaher (NYSE:DHR) shares have jumped following two important developments. Its Leica Biosystems unit unveiled new AI-powered digital pathology solutions, and a favorable shift in US pharmaceutical tariffs is energizing the broader sector. See our latest analysis for Danaher. Momentum seems to be swinging back in Danaher’s favor, with strong sector tailwinds and new AI-driven products helping the company rebound after a lackluster stretch. While the 1-year total shareholder return has..."
05-10-2025,Jim Cramer on Danaher: “It Has Been a Huge Disappointment”,Yahoo,"Danaher Corporation (NYSE:DHR) is one of the stocks Jim Cramer put under the microscope. Cramer discussed it while highlighting the performance of healthcare stocks. He said: “Some of these healthcare stocks seem played out already to you, perhaps. I mean, Merck was up 7% just today. Charitable holding Danaher also leaped more than 7%. But […]"
05-10-2025,Jim Cramer on Thermo Fisher: “They Really Got Hurt By COVID”,Yahoo,"Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the stocks Jim Cramer put under the microscope. When Cramer was asked about the stock, he commented: “Oh yeah… they really got hurt by COVID. I gotta tell you, as good as Marc Casper is at Thermo Fisher, I’m still saying that Danaher’s better. They’ve both been […]"
07-10-2025,Jim Cramer Wonders If He Gave Up On Danaher (DHR) “At The Bottom”,Yahoo,"We recently published 12 Stocks Jim Cramer Mentioned In An Episode Where He Briefly Commented On Data Centers. Danaher Corporation (NYSE:DHR) is one of the stocks Jim Cramer recently discussed. Jim Cramer hasn’t held back when commenting on Danaher Corporation (NYSE:DHR) in 2025. Early in the year, he criticized the firm’s management for being “smug” […]"
07-10-2025,4 Stocks That Aren’t Too Hot to Buy Right Now,Yahoo,"Most stocks have rallied too much to look like buys.  The rally is perched on three pillars—falling inflation, lower interest rates, and rapid growth of spending on artificial intelligence—and the collapse of any one could bring down the market.  Then, they tagged those that placed high in the bank’s quantitative model—stocks with the best combination of upward earnings forecast revisions from analysts, high-quality financial metrics, strong price momentum, and low “crowding.”"
08-10-2025,Danaher Corporation (DHR): A Bull Case Theory,Yahoo,"We came across a bullish thesis on Danaher Corporation on Heavy Moat Investments’s Substack. In this article, we will summarize the bulls’ thesis on DHR. Danaher Corporation’s share was trading at $185.91 as of September 24th. DHR’s trailing and forward P/E were 39.47 and 21.69 respectively according to Yahoo Finance. Danaher Corporation has long been a central […]"
08-10-2025,Rothschild & Co Downgrades Danaher (DHR),Fintel,
08-10-2025,2 Cash-Producing Stocks Worth Your Attention and 1 We Avoid,Yahoo,"A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand."
08-10-2025,Evercore ISI Group Maintains Danaher (DHR) Outperform Recommendation,Fintel,
09-10-2025,Is Repligen (RGEN) The Best Healthcare Stock to Buy Now?,Yahoo,"We recently published Top 10 Stock Recommendations You Can’t Miss Amid Growing AI Bubble Fears. Repligen Corporation (NASDAQ:RGEN) is one of the top recommended stocks. Dan Veru, Palisade Capital Management senior partner and CIO, recently talked about Repligen, a life sciences company involved in the development and production of materials used in the manufacture of […]"
